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   ZUSAMMENFASSUNG 
ZUSAMMENFASSUNG 
Die Verknüpfung einer exergonischen mit einer endergonischen Reaktion zur Ermöglichung 
der letzteren ist eine in biologischen Systemen weit verbreitete Strategie. Energetisch 
benachteiligte Elektronenübertragungsreaktionen im Rahmen der reduktiven Aktivierung von 
Nitrogenasen, Radikal-abhängigen β,α-Dehydratasen, der zu diesen verwandten Benzoyl-
CoA-Reduktasen und diversen Cobalamin-abhängigen Methyltransferasen sind gekoppelt an 
die Hydrolyse von ATP. Der Methylgruppentransfer des reduktiven Acetyl-CoA-Weges von 
Carboxydothermus hydrogenoformans erfordert den Co(I)-Zustand des Corrinoid/Eisen-
Schwefel Proteins (CoFeSP). Um diese superreduzierte Form nach einer oxidativen 
Inaktivierung zu regenerieren ist ein „Reparaturmechanismus“ erforderlich. Ein offenes 
Leseraster (orf7), welches möglicherweise für eine reduktive Aktivase von Corrinoid 
Enzymen (RACE) kodiert, wurde in dem Gencluster der am reduktiven Acetyl-CoA-Weg 
beteiligten Proteine entdeckt. Im Rahmen dieser Arbeit wurde dieses potenzielle RACE 
Protein biochemisch und strukturell charakterisiert. 
 
Die Übertragung eines Elektrons durch das orf7-Produkt ist ATP-abhängig (Rate = 1,27 ± 
0,23 min-1 in Anwesenheit von 1 mM ATP) und stuft das Protein als ATP-abhängigen, 
reduktiven Aktivator von CoFeSP (RACo) ein. Analytische Gelfiltration und ITC zeigten, 
dass RACo – unabhängig vom eigenen Redoxzustand und der Anwesenheit von Nukleotiden 
– ausschließlich mit der inaktiven Co(II)-Form von CoFeSP einen stabilen Komplex bildet 
(KD von 18,1 ± 2,8 nM). In dem RACo:CoFeSP-Komplex wurde eine um ca. 25-fach erhöhte 
spezifische ATPase-Aktivität von RACo gemessen. Mittels spektroskopischer Methoden 
(Resonanz-Raman- und EPR-Spektroskopie) konnte demonstriert werden, dass die 
Komplexbildung ausschließlich die Koordination und elektronische Struktur des Cobalamin-
Kofaktors beeinflusst, während die Struktur der beiden [FeS]-Zentren nicht beeinträchtigt 
wird. Das Redoxpotential des Elektronenakzeptors wird durch Wechselwirkungen mit RACo 
um mehr als -150 mV verschoben, was durch Redoxtitrationen in Verbindung mit EPR-
Spektroskopie gezeigt werden konnte. Die Kristallstruktur des RACo:CoFeSP-Komplexes, 
die in dieser Arbeit bis zu einer Auflösung von 2.5 Å gelöst wurde, zeigte große 
Umlagerungen der beweglichen N – und C–terminalen Domänen von CoFeSP. Des Weiteren 
deckte die Struktur auf, dass RACo in zwei verschiedenen Konformationen vorliegen kann. 
Die im Komplex beobachtete geöffnete Konformation liefert eine Erklärung für die im 
Komplex gemessene erhöhte ATPase-Aktivität. Das Kobalt des Cobalamin-Kofaktors wird 
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im Komplex von einem Serinrest von RACo (Ser398) koordiniert. Dieser spielt vermutlich 
für die oxidationsstufenabhängige Partnererkennung eine wichtige Rolle. 
 
Auf Grundlage der in dieser Arbeit gewonnenen Ergebnisse wurde ein Mechanismus für die 
ATP-abhängige Aktivierung entworfen. Dieser gibt Einblicke wie die durch ATP-Hydrolyse 
bereitgestellte Energie einen energetisch ungünstigen Elektronentransfer ermöglichen kann. 
Hierzu kombiniert RACo das Ausgleichen von Bindungsenergien mit Modulationen am 
Elektronenakzeptor. Eine vergleichbare Strategie wurde bisher in keinem anderen ATP-
abhängigen Elektronenübertragungssystem wie dem von Nitrogenasen, Radikal-abhängigen 
β,α-Dehydratasen oder Benzoyl-CoA-Reduktasen beobachtet und könnte ein für RACE 
Proteine allgemein gültige Eigenschaft darstellen. 
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   SUMMARY 
SUMMARY 
The principle of coupling an exergonic to an endergonic reaction to enable the latter is a 
widespread strategy in biological systems. Unfavoured electron transfer reactions in the 
reductive activation of nitrogenases, radical-dependent β,α-dehydratases and the related 
benzoyl- CoA reductases, as well as different cobalamin-dependent methyltransferases are 
coupled to the hydrolysis of ATP. The reductive acetyl-CoA pathway of Carboxydothermus 
hydrogenoformans relies on the superreduced Co(I)-state of the corrinoid/iron-sulfur protein 
(CoFeSP) that requires a “repair mechanism” in case of incidental oxidation. An open reading 
frame (orf7) coding for a putative reductive activase of corrinoid enzymes (RACE) was 
discovered in the gene cluster of proteins involved in the reductive acetyl-CoA pathway. In 
this study, this putative RACE protein was biochemically and structurally characterised. 
 
The one-electron activation of Co(II)-CoFeSP by the orf7 product strictly depends on ATP 
(rate = 1.27 ± 0.23 min-1 in the presence of 1 mM ATP) and classifies this protein as the ATP-
dependent reductive activator of CoFeSP (RACo). RACo forms a tight complex only with the 
inactive Co(II) state of CoFeSP irrespective of its own redox state and the presence of 
nucleotides, as determined by analytic gel filtration and ITC (KD of 18.1 ± 2.8 nM). The 
specific ATPase activity of RACo was enhanced approximately 25-fold upon formation of the 
RACo:CoFeSP complex. By spectroscopic methods (resonance Raman and EPR 
spectroscopy) it could be shown that complex formation affected the coordination and the 
electronic structure of the cobalamin cofactor exclusively but none of the present [FeS] 
clusters. The midpoint potential of the electron accepting cofactor is shifted by more than -
150 mV by the interactions with RACo demonstrated by redox titrations combined with EPR. 
The crystal structure of the RACo:CoFeSP complex, which was solved to a resolution of 
2.5 Å, gave further insights. Besides large movements of the flexible N- and C-terminal 
domain of CoFeSP, the structure revealed that RACo could exist in two different 
conformations. The open conformation of RACo within the complex offers an explanation for 
the higher ATPase activity measured for the RACo:CoFeSP complex. In the complex a serine 
residue (S398) of RACo directly coordinates the cobalt ion and is probably responsible for the 
oxidation-state dependent partner recognition.  
 
Based on the results of this study, a mechanism for the ATP-dependent reactivation of 
CoFeSP was deduced providing insights into how the energy provided by ATP could trigger 
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this unfavourable electron transfer. The reductive activator of CoFeSP combines balance of 
binding energies and modulations of the electron acceptor to promote the uphill electron 
transfer to CoFeSP. A comparable strategy has not been observed in other ATP-dependent 
electron transfer systems like nitrogenases, radical-dependent β,α-dehydratases and benzoyl- 
CoA reductases and could be a universal feature of RACE proteins. 
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   INTRODUCTION 
I. INTRODUCTION 
1. Energy Transduction 
“The living cell avoids direct utilization of external energy sources in the performance of 
useful work. It transforms energy of these sources to a convertible energy currency, i.e. ATP, 
ΔμH+ or ΔμNa+, which is then spent to support various types of energy consuming 
processes.” (1) 
As early as in 1941, Fritz Lipmann mint the concept of ATP being the cellular energy 
currency (2). The “first law” of bioenergetics (1) had to be extended later by including the 
protonic and sodium potentials (3, 4). Energy provided by those is used chemically in 
biosynthetic reactions (ATP synthesis, reverse electron-transfer), “osmotically” (uphill 
transport of solutes) and mechanically (motility of transport and other metabolic processes (1, 
5). Or short, life depends on the interplay of energy production and consumption. How 
organisms convert environmental sources of light and redox energy to cellular energy sources 
in the form of high energy compounds like adenosin-5´-triphosphate (ATP), ion gradients or 
conformational energy of proteins (6) remains partially elusive despite intensive research. It is 
the discipline of bioenergetics that refers to the study of energy transformation in living 
organisms. Milestone in the investigation of the energy balance of organisms, e.g. of energy 
transduction, is the discovery of the chemi-osmotic mechanism of the coupling of electron 
and hydrogen transfer to phosphorylation reaction in the respiratory chain during ATP 
synthesis (7). Electron transfer reactions mediated by metal containing cofactors bound to 
proteins are generally important processes in nature (8). Whereas spontaneous electron 
transfer reactions occur thermodynamically “downhill” and profit energy, nature has 
developed different strategies to perform less favourable redox processes. The transduction of 
energy, e.g. the combination of one exergonic (favoured) and an endergonic (unflavoured) 
reaction in the manner that the overall reaction is exergonic, is achieved by connecting uphill 
electron transfer reactions to catalysis, atom and/or ion transfer (1, 8). How two energetic 
processes are efficiently coupled has been the main focus in (structural) bioenergetics (5). 
Electron transfer systems coupled to the hydrolysis of ATP are abundant and will be 
introduced in the following chapters.  
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2. ATP-Dependent Electron Transfer Systems 
Electron donors with moderate reduction potentials are often used for the reduction of low-
potential clusters. Beside flavin-based electron bifurcation (9, 10), less favoured electron 
transfer reactions are thermodynamically driven by the direct or indirect coupling to an 
energy providing reaction like the hydrolysis of ATP (11).  
Over the last decades, ATP-dependent electron transfer reactions have been investigated as 
important parts of biological relevant reactions in the carbon and nitrogen cycle. Activators or 
reductases reducing low-potential metal clusters are found in nitrogenases, β,α-dehydratases 
and corrinoid enzymes among others (12–17). The by far most intensively investigated ATP-
dependent electron transfer system is the reduction of dinitrogenase by the dinitrogenase 
reductase (18–24), but in the last years studies on similar systems have gained attraction. The 
next chapter gives a short introduction to different types of ATP-dependent activation systems 
found in the global carbon and nitrogen cycle. 
2.1. Nitrogenase 
For the synthesis of essential biological building blocks like nucleic acids, amino acids and 
amino sugars, all organisms require dinitrogen (N2). Even though it is the most frequent 
element in the atmosphere (approximately 80 vol.%), the bioavailability of molecular nitrogen 
is limited due to the stable triple bond (945 kJ/ mol) (25). Under physiological conditions 
(25 °C, 1 atm) dinitrogen can be converted into ammonia, the only form of N2, which can be 
transformed into biomass but the cleavage of the triple bond is a highly energy consuming 
reaction. The reaction within the biogeochemical nitrogen cycle is known as nitrogen fixation 
(26). It is catalysed by the oxygen sensitive protein complex nitrogenase (12, 18, 23, 27). 
 
N2+ 8H
++ 8e−+16ATP+16H2O →2NH3+ H2+16ADP+16Pi   (1) 
Nitrogenase consists of two components, the Fe-protein (dinitrogen reductase) and the MoFe-
protein (dinitrogenase) where the reduction of nitrogen takes place. Under and only under 
turnover conditions the two proteins assemble to form the nitrogenase complex (12, 24, 28, 
29). 
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The Fe-protein or dinitrogenase reductase is a γ2-homodimer. A [4Fe4S] cluster is located at 
the interface of the two subunits (Figure 1A) (30, 31). Every monomer of the Fe-protein 
contains one nucleotide-binding site with structural motifs found in nucleotide-binding switch 
and G-proteins, which classify the Fe-protein as a P-loop NTPase (32). The Walker A or P-
loop motif (GXXXXGKS/T) is a widespread structural unit and triggers conformational 
changes upon nucleotide-binding (20, 33–35). The Fe-protein is the only known physiological 
electron donor for the MoFe-protein. 
 
Figure 1: Nitrogenase components. (A) The two γ-subunits (cyan and green cartoon) of the Fe-protein are 
bridged by a [4Fe4S] cluster (stick model), which is located in the interface of the two monomers (B). The 
FeMo-protein is a α2β2-heterotetramer. The α-subunits are coloured in red and the β-subunits in blue. The 
catalytic unit consists of one αβ-heterodimer and contains one P-and FeMo-cofactor, respectively (stick models). 
The figure is based on the PDB entries 1G5P (31) and 3U7Q (36). 
The FeMo-protein, also called dinitrogenase, is a α2β2-heterotetramer binding two unique 
metal centres, named P-cluster and FeMo-cofactor (Figure 1B). Each catalytical unit, the αβ-
heterodimer, contains one P-cluster ([8Fe:7S]) and one FeMo-cofactor ([7Fe:Mo:9S:X:R-
homocitrate] where the reduction of nitrogen takes place (37, 38). The interstitial ligand X 
was assigned recently as a carbon atom by analysis of a high-resolution structure and ESEEM 
spectroscopy (36).  
The crystal structure of the MgADP·AlF4- stabilised nitrogenase complex, composed of one 
MoFe-protein and two Fe-proteins (α2β2(γ2)-composition), which contains two catalytic units 
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for the nitrogen reduction, gave first insights into the transition state during turnover 
conditions (Figure 2) (28, 39).  
 
Figure 2: The nitrogenase complex. Cartoon presentation along the 2-fold symmetry axis of the nitrogenase 
complex based on the PDB entry 1N2C (28). The Fe-protein and MoFe-protein are coloured as in Figure 1. The 
cofactors are shown as stick models. Ca-ions are presented as green spheres. 
In the complex, the [4Fe4S] cluster of the Fe-protein is located in the interface between the 
two proteins. An edge-to-edge distance to the P-cluster of about 14 Å was determined, which 
is a reasonable distance for electron transfer (Figure 3) (40, 41). The transfer is proposed from 
the reduced [4Fe4S] cluster of the Fe-protein to the P-cluster coupled to the hydrolysis of 
ATP. The electron is then transferred from the P-cluster to the FeMo-cofactor and is utilised 
in the reduction of nitrogen (28). Recently, a different model for the electron transfer was 
suggested. In the “deficit-spending” model, first an electron is transferred from the P-cluster 
to the active site, e.g. the FeMo-cofactor. The oxidised P-cluster shows a “deficit” and 
“backfill” electron transfer from the [4Fe4S] cluster of the Fe-protein to the P-cluster is 
necessary to fill the electron gap (Figure 3) (22, 42, 43).  
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Figure 3: The nitrogenase proteins with cofactors. (A) The Fe-protein (green and cyan, left), one αβ-unit of 
the MoFe-protein (red and blue, right) and all cofactors are shown. The Fe-protein has two ATP molecules 
bound. The [4Fe4S] cluster of the Fe-protein, as well as the P-cluster and FeMo-cofactor of the MoFe-protein 
are represented as ball and stick models. Fe-atoms are coloured in orange, sulfur in yellow, C-atoms in grey, O-
atoms in red, N-atoms in blue and the Mo-atom in cyan. This figure was prepared from the PDB file 2AFK (29). 
(B) Changes of the Fe-protein of nitrogenase. Superimposition of both Fe-protein structures (ribbon 
presentation) demonstrates the 5 Å-displacement of the [4Fe4S] cluster. Free Fe-protein (1G5P) (31) is shown in 
grey. The monomers of the Fe-protein in the complex (1N2C) (28) are coloured in green and cyan; the [4Fe4S] 
cluster in yellow and orange. 
In all models, conformational changes of the Fe-protein act as a switch for the association and 
dissociation of the Fe-protein:MoFe-protein complex (22, 35, 42). In the complex, the 
[4Fe4S] cluster is displaced by 5 Å towards the surface (Figure 3B) resulting in a shortening 
of the edge-to-edge distance to the P-cluster (19, 21, 22, 28, 35).  
The investigation of the electron transfer within the nitrogenase complex and of the overall 
mechanism of the nitrogen conversion to ammonia at the MoFe-cofactor has been fostered in 
the last decades. A detailed understanding of the biological nitrogen fixation, meaning the 
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understanding of the nitrogenase mechanism and its active site, are of common interest to 
promote the development of a sustainable technical process replacing the Haber-Bosch 
technique. 
2.2.  (R)-2-Hydroxyacyl-CoA-Dehydratase and the Related Benzoyl-CoA Reductase 
2.2.1. (R)-2-Hydroxyacyl-CoA-Dehydratase 
In the absence of electron acceptors such as oxygen, nitrate or sulfate, only few anaerobes, 
“fusobacteria” and clostridia are able to profit from α-amino acids as energy substrates. 
Several Clostridia and Fusobacterium nucleatum are able to ferment 12 of the 20 
proteinogenous amino acids by deamination to the corresponding (R)-2-Hydroxyacyl-CoA 
derivatives (44). They are converted to enoyl-CoAs in an atypical dehydration reaction 
catalysed by the two-component system (R)-2-Hydroxyacyl-CoA dehydratases. The β,α-
dehydration is a chemically challenging reaction due to the high pK of 40 of the β-proton, 
which is too high to be abstracted by a protein residue. The reaction depends on the reductive 
generation of ketyl radicals on the substrate (45). Thereby, a single highly energetic electron 
functions as a cofactor (Figure 4A) (44–46).  
The 2-hydroxyacyl-CoA-dehydratases are two-component systems similar to nitrogenase and 
consist of component A, a reductive activator, and of component D, the dehydratase. The 
reductive activator is a homodimer with one [4Fe4S] cluster bridging the two monomers 
(Figure 4C). Like in the Fe-protein of nitrogenase, a nucleotide-binding site is present in each 
monomer. Its structural fold classifies the activator as a member of the ASKHA (acetate and 
sugar kinases, heat shock 70 protein / actin fold) protein family (47, 48). The dehydratase, or 
component D, is a heterodimer containing one or two [4Fe4S] clusters depending on the 
organism. The crystal structure of the (R)-2-hydroxyisocaproyl-CoA dehydratase from C. 
difficile revealed two [4Fe4S] clusters at a distance of 12 Å (Figure 4B). The cluster of the α-
subunit belongs to the active site whereas the second cluster bound to the β-subunit, serves as 
a “reservoir” and protects the electron from unwanted side reactions (49). 
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Figure 4: (R)-2-Hydroxyisocaproyl-CoA-Dehydratase components. (A) Proposed mechanism for the 
dehydration of (R)-2-hydroxyacyl-CoA via a ketyl radical anion including the ATP-dependent activation of the 
dehydratase by its activator. The scheme was adapted from Kim et al. (44). (B) The (R)-2-Hydroxyisocaproyl-
CoA-dehydratase (component D) in its substrate bound state. The α-subunit where the 2-hydroxyisocaproyl-CoA 
binds in direct proximity to the α-cluster (cyan stick model) is shown in red. The β-subunit with the “reservoir”-
[4Fe4S] cluster is coloured in blue. The figure was prepared based on the PDB entry 3O3M (49) (C) The 
homodimer of the activator of (R)-2-hydroxyisocaproyl-CoA-dehydratase is shown in its ADP-bound state. The 
[4Fe4S] cluster (yellow and orange spheres) bridges the two monomers (displayed in cyan and green). The 
nucleotide is shown as violet stick model. The figure was prepared based on the PDB 4EHT (50).  
Crystal structures of the activator with and without bound nucleotides, indicate that the 
protein is able to adapt two different conformational states (Results and Discussion Figure 45) 
(50). In the nucleotide-free state, it adapts an open conformation. The binding of the 
nucleotide prepares component A for the formation of the dehydratase complex by switching 
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to the closed conformation. Complexes of 2-hydroxyisocaproyl-CoA dehydratase and its 
activator as well as between the activator and the (R)-2-hydroxyisocaproyl-CoA dehydratase 
from Clostridium difficile were observed in gel filtration experiments in the presence of the 
ATP-transition state analogue AMP-PNP (50, 51). Electron transfer from the reduced [4Fe4S] 
cluster of the activator within the activation complex is induced by the hydrolysis of ATP. 
Once activated, the dehydratase is able to fulfil about 10,000 turnovers before the electron is 
lost by oxidation and another ATP-dependent activation by its activator is necessary (51, 52).  
2.2.2. Benzoyl-CoA Reductase 
Benzoyl-CoA reductase from the denitrifying bacterium Thauera aromatica acts in the 
reductive dearomatisation of benzoyl-CoA. The reduction of the aromatic benzoyl-CoA to 
cyclohexa-1,5-diene-1-carbonyl-CoA is driven by a stoichiometric ATP hydrolysis (Figure 
5A) and is catalysed by a heterotetramer with a ABCD composition (Figure 5B) (14, 53, 54). 
The complex can be divided into several heterodimeric units according to their function. The 
subunits A and D resemble the activator and dehydratase of 2-hydroxyglutaryl-CoA 
dehydratase and represent the activating module. Subunits B and C form the substrate 
reduction module. The activating module contains two ATP-binding sites of the ASKHA-type 
and a [4Fe4S] cluster is coordinated by both monomers at the interface. Benzoyl-CoA is 
bound to the substrate reduction module binding two additional [4Fe4S] clusters (14, 53, 54). 
The reduction of benzoyl-CoA can be described as an enzymatic Birch-like reduction (55). A 
thioester ketyl radical emerges as intermediate like in the homologous R-hydroxyacyl-CoA 
dehydratases. Electron transfer from the activating module to the substrate is coupled to 
stoichiometric ATP hydrolysis (14, 53–55). 
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Figure 5: Reaction and composition of benzoyl-CoA reductase of T. aromatica. (A) ATP-dependent 
conversion of benzoyl-CoA catalysed by benzoyl-CoA reductase is an enzymatic Birch-like reduction. (B) 
Postulated subunit and cofactor composition. Subunits belonging to the same functional module are coloured 
equally. The substrate reduction unit is shown in green, the activating unit with two ATP-binding sites in brown, 
respectively. The figure was adapted from Unciuleac et al. (14). 
2.3. Reductive Activators of Corrinoid-Dependent Methyltransferases: RACE Proteins 
Cobalamin and the relative corrinoids act in methyl transfer reactions. Beside the well-studied 
cobalamin-dependent methionine synthase (56–58), methyltransferase systems, depending on 
corrinoid proteins, have been described for anaerobic bacteria and archaea (59–62).  
Methanogenic methyltransferases catalyse the transfer of a methyl group from methanol, 
methylamines or dimethylsulfides to coenzyme M (63, 64). In their function these 
methyltransferases conform the O-demethylases found in acetogenic bacteria like 
Acetobacterium dehalogenans. O-demethylases mediate the cleavage of phenyl methyl ethers 
providing a methyl group utilised as carbon and energy source. The inducible four-component 
system consists of methyltransferase I and II (MT I and II), a corrinoid protein (CP) and an 
activating enzyme (AE) (65, 66). MT I and II as well as the corrinoid protein act in the methyl 
transfer from the substrate (for example vanillate, veratrol) to tetrahydrofolate. The MT I 
binds the phenyl methyl ether, catalyses the cleavage of the ether bond and transfers the 
methyl group to the reduced CP protein (in the reduced Co(I) state). In the second methyl 
transfer reaction mediated by MT II, tetrahydrofolate is converted to methyl-tetrahydrofolate, 
which is needed for the production of acetate in the acetogenic catabolism (Figure 6) (65, 66). 
The redox potential of the cob(II)alamin/cob(I)alamin couple is very negative (ESHE < -
500 mV) (67–69) and inactivation by incidental oxidation to Co(II) may occur in the cells 
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(70). The activating enzyme is able to regain the superreduced Co(I) state in an ATP-
dependent reaction (Figure 6) (16, 17, 65, 71–74).    
 
Figure 6: Scheme of the methyl transfer reactions mediated by the components of the O-demethylases. 
Methyltransferase I (MT-I) transfers the methyl group from the phenyl methyl ethers to the reduced corrinoid 
protein (Co(I) state) resulting in methylated corrinoid (CH3-Co(III) state). The two active states are shown in 
green. MT-II catalyses the conversion of tetrahydrofolate (FH4) to methyl-tetrahydrofolate (CH3-FH4). The 
fourth component of the O-demethylase, the activating enzyme, provides a “repair“ mechanism in case oxidation 
inactivates the corrinoid protein to the Co(II) state (red). The overview was adapted from Kaufmann et al. (66).  
In numerous operons of methanogenic MTs a gene, often of unknown function, is located in 
proximity to the genes encoding methyltransferases. RamA or MapA of the methanogenic 
Methanobrevibacter smithii and Methanosarcina bakeri for example code for an activating 
enzyme similar to the AE of O-demethylase (15). Schilhabel and co-workers compared the 
operons of the O-demethylase with operons of methanogenic MT systems as well as with 
operons of other anaerobic methyltransferases and CODH/ACS complexes (17). The majority 
of hits with sequence identities between 20 and 41 % are metal binding proteins of unknown 
function that are grouped in the Cluster of Orthologous Groups (COG) database as COG3894. 
Whereas the bacterial proteins show motifs of a N-terminally bound [2Fe2S] cluster, patterns 
of 2x [4Fe4S] cluster were identified in archaeal sequences (Figure 7) (17).  
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Figure 7: Comparison of orthologous gene clusters involved in the activation of corrinoid proteins. The 
gene clusters of four bacteria (a-d) and two archaea (e-f) containing the COG3894 genes are shown. The 
trimethylamine MT (a) and CODH/ACS (b) of Dehalobacter hafniense DCD-2, CODH/ACS of Moorella 
thermoacetica (c), the activating enzyme (OdmC) of Acetobacterium dehalogenans (d), the methanol:coenzyme 
M (CoM) MT of Methanobrevibacter smithii (e) and the monomethylamine:CoM Mt of Methanosarcina barkeri. 
Some gene clusters have been orientated in reverse direction for the comparison of the orthologs and are marked 
with an asterisk. This figure was adapted from Schilhabel et al. (17). 
As in all methyltransferases and CODH/ACS complexes the superreduced Co(I) state of the 
corrinoid protein plays a crucial role in the catalytic cycle, the genes probably code for FeS 
proteins participating in the activation and reduction of protein bound corrinoids. The 
products of these genes likely code for reductive activases of corrinoid enzymes and the term 
RACE was introduced for this protein family recently (17). Biochemical characterisation of 
members of this protein family is still in the early stage of development and includes 
predominantly the activating enzyme of O-demethylases (15, 16, 73, 74).  
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3. Reductive Activation in the Reductive Acetyl-CoA Pathway 
3.1. Carbon Fixation via the Reductive Acetyl-CoA Pathway in Anaerobic Bacteria 
The fixation of inorganic carbon and its conversion to organic compounds can be considered 
as the starting point of biological evolution (75). Plants and the majority of prokaryotes fix 
approximately 1017 g of carbon dioxide into biomass in the reductive pentose phosphate 
(Calvin-Benson) cycle (76). Beside the Calvin-Benson cycle five alternative autotrophic 
pathways of CO2-fixation exist, namely the reductive citric acid cycle, the 3-
hydroxypropionate bicycle, the hydroxypropionate-hydroxybutyrate cycle, the dicarboxylate-
hydroxybutyrate cycle and the reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) 
(75, 76). Approximately 10 % of the annually produced 1013 kg of acetic acid derive from 
acetogens (77) and this pathway can be considered as a bacterial version of the Monsanto 
process. The importance of microbial carbon fixation to maintain a viable atmosphere is also 
obvious as every year 1011 t of carbon dioxide – corresponding to 10 % of the CO2 content of 
the air – and approximately 108 t of the greenhouse gas carbon monoxide are fixed 
autotrophically (76, 78). The reductive acetyl-CoA pathway is the most ancient C1 carbon 
fixation pathway and is assumed to be the closest to the ancestral autotrophic carbon fixation 
pathway (75, 79). 
Figure 8 gives an overview of the reductive acetyl-CoA pathway used by anaerobic bacteria 
(acetogens) as main mechanism for energy conservation and for the synthesis of acetyl-CoA 
spent in cell carbon (80) . 
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Figure 8: The reductive acetyl-CoA or Wood-Ljungdahl pathway of Moorella thermoacetica. The two 
branches of the pathway are highlighted in red (Methyl/Eastern branch) and blue (Western/Carbonyl branch). In 
total, two molecules of carbon dioxide are fixed to acetyl-CoA, which is used in the cell carbon cycle or for the 
production of energy. The metalloenzymes acting in the carbonyl branch are given in white. The scheme was 
adapted from Ragsdale and Pierce (77). 
The reductive acetyl-CoA pathway is divided into two branches. One molecule of CO2 is 
stepwise reduced in the eastern/methyl branch to a methyl group bound to tetrahydrofolate 
(Figure 8, red box). The methyl group from CH3-tetrahydrofolate is transferred to the 
corrinoid/iron-sulfur protein (CoFeSP) by methyltransferase (MeTr). CO-Dehydrogenase 
(CODH) in the western/carbonyl branch reduces another molecule of CO2 to carbon 
monoxide. Condensation of the CO and the bound methyl group catalysed by acetyl-CoA-
synthase (ACS) yields acetyl-CoA, which is incorporated into cell carbon or used for energy 
production in the cell (Figure 8, blue box) (77, 78, 81) . The eastern branch of the reductive 
acetyl-CoA pathway equals the folate-dependent one-carbon metabolic pathway found in 
humans and bacteria but the western branch with highly oxygen-sensitive metalloenzymes is 
unique to acetogens, methanogens and sulfate reducers (77, 81).  
The extremely thermophilic and strictly anaerobic, gram-positive eubacterium 
Carboxydothermus hydrogenoformans was isolated from a hot spring in Kunashir Island. It 
was considered to be an obligate CO autotroph (82), which gains energy fermentatively by 
performing the water shift reaction at lower temperatures than technical catalysts do. Hence 
the application of microorganisms like C. hydrogenoformans in the production of hydrogen 
gas at low CO concentrations has gained attraction in the field of biotechnology (83, 84). 
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Microbes using CO as carbon source depend on carbon monoxide dehydrogenases (CODH), 
which catalyse the oxidation of CO to CO2. In the genome of C. hydrogenoformans five genes 
encoding for CODH homologs are present (named CODH I-V) and act in energy conservation 
and oxidative stress response amongst others (83, 85). CODH-III is located in the gene cluster 
coding for the enzymes involved in carbon fixation via the reductive acetyl-CoA pathway 
(Figure 9, red box) (83). 
 
Figure 9: Genes encoding CODHs and their location in the genomic DNA of C. hydrogenoformans. The 
gene cluster including CODH-III and genes coding for enzymes acting in carbon fixation via the reductive 
acetyl-CoA pathway is highlighted with a red box. This figure was adapted from Wu et al.  (83). 
The investigation of enzymes acting in the reductive acetyl-CoA pathway of M. 
thermoacetica has intensively been performed in the last 30 years (81, 86, 87). Most of these 
enzymes including ACS, CODH II, the Ni-binding ATPase CooC1 and CoFeSP of the 
hydrogenogenic bacterium C. hydrogenoformans (Figure 9) have been functionally and 
structurally investigated (33, 88–94). 
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3.2. The Corrinoid/Iron-Sulfur Protein of Carboxydothermus hydrogenoformans at the 
Heart of the Reductive Acetyl-CoA Pathway 
The corrinoid/iron-sulfur protein is a heterodimer consisting of two subunits, the large subunit 
CfsA and the small CfsB subunit, respectively. As the name indicates, CoFeSP binds two 
cofactors with both of them located in the large subunit, CfsA; namely a Coβ-aqua(5,6-
dimethylbenzimidazolylcobamide) or cobalamin, and a cubane type [4Fe4S] cluster (95, 96). 
The structure of CoFeSP of C. hydrogenoformans was solved some years ago and 
demonstrates that the large subunit, CfsA, is divided into different domains (89, 94). The 
[4Fe4S] cluster is bound to the N-terminal domain with a four-helix-bundle-like architecture 
which is connected to the middle domain composite of a (βα)8-barrel, by a flexible linker (94). 
The C-terminal domain is linked to the middle domain by a proline-rich linker and binds the 
cobalamin cofactor, which is sandwiched between the C-terminal part of CfsA and CfsB 
(Figure 10) (89, 94). CfsB contains a Rossmann-like fold consisting of a parallel four-
stranded β-sheet framed by two α-helices. A “cap-helix” is in van-der-Waals distance and 
interacts with the lower side of the corrin macrocycle (89, 94). On the upper face of the corrin 
moiety, a water molecule directly coordinates the cobalt ion. In contrast to other B12-
dependent proteins like methionine synthase (MetH), the cobalamin cofactor is bound base-
off, e.g. neither the dimethylbenzimidazole chain nor a protein side chain coordinates the 
cobalt (Figure 10, inset). The base-off / His-off conformation results probably in a 
stabilisation of the cob(I)amide by about +100 mV compared to the base- or His-on states 
(68). The structures solved in 2006 (89) and 2011 (94) show both the inactive Co(II)-state of 
CoFeSP. 
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Figure 10: Overall structure of CoFeSP of C. hydrogenoformans. The structure including the N-terminal 
[4Fe4S] cluster domain is shown as cartoon. The small subunit (CfsB) is coloured in yellow. The large subunit 
CfsA contains three domains. The N-terminal domain is illustrated in blue, the middle domain in green and the 
C-terminal domain in red. The linker connecting the N-terminal and C-terminal domain to the middle domain, 
respectively, is shown in purple. The [4Fe4S] cluster is presented as spheres (iron atoms in orange, sulfur in 
yellow). The cobalamin cofactor is shown as cyan stick model. The coordination environment of the cobalamin 
cofactor is illustrated in the inset. The cobalt ion (shown as pink sphere) binds a water molecule on the upper 
face of the corrin ring. On the lower side T374 of the cap-helix is in van-der-Waals distance. The subunits are 
coloured as in the main figure. The figure was prepared using the PDB entry 2YCL (94). 
CoFeSP is at the heart of the reductive acetyl-CoA pathway by bridging the methyl and the 
carbonyl branch and functions as a methyl group carrier (Figure 8). The protein accepts a 
methyl group from CH3-H4folate in a reaction catalysed by MeTr (reaction 2) (97).  
 
CH3 − H4 folate + Co(I)FeSP + H
+ ↔ CH3 − Co(III)FeSP + H4 folate  (2) 
Methylated CoFeSP transfers the methyl group to the A-cluster of ACS (88). Acetyl-CoA is 
synthesised at the Ni–Ni–[4Fe4S] site in a condensation reaction of CoA, CO (from CO2 
reduction by CODH) and the methyl group (81). 
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CH3 − Co(III)FeSP + CO + CoA ↔ CH3(CO)CoA + Co(I)FeSP    (3) 
As shown in previously reported structures of CoFeSP (89, 94) and CoFeSP in complex with 
its methyltransferase (98), the protein exists in several conformations depending on the 
environment and its interaction partners. The MC- and NM-linker connecting the cofactor 
carrying domains to the middle domain of CfsA, provide the basis for its flexibility (Figure 
10) (89, 94, 9).  
The function of the [4Fe4S] cluster was described as the conduit for an electron transferred 
from an external donor to the cobalamin (99, 100). A distance of approximately 60 Å between 
the two centres (94) contradicts direct electron transfer. Large conformational changes in the 
protein would be required to reduce the distance of the cofactors to 14 Å or less in order to 
enable the transfer of an electron (40). However, activation by interactions with another 
protein has not been described so far. 
3.3. An Open Reading Frame in the Gene Cluster of the Reductive Acetyl-CoA Pathway – 
Coding for a Putative RACE Protein? 
During the catalytic cycle of CoFeSP, the cobalamin cofactor cycles between two active 
states: the superreduced Co(I) state accepting the methyl group from MeTr and the methyl-
bound Co(III)-CoFeSP interacting with ACS (81). The Co(I) state is highly sensitive to 
incidental oxidation and inactivation to Co(II) occurs approximately every 100 turnovers 
(100), which indicates the existence of a reductive activation system for the reduction of the 
Co(II) state.In the gene cluster coding for the proteins acting in the reductive acetyl-CoA 
pathway of M. thermoacetica an open reading frame is situated in proximity to the acsC and 
acsD genes coding for the two subunits of the corrinoid/iron-sulfur protein (101). This open 
reading frame, annotated orf7, is also located between the genes coding for CoFeSP in the 
genome of C. hydrogenoformans (Figure 11) (83). 
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Figure 11: Gene cluster of proteins of the reductive acetyl-CoA pathway of C. hydrogenoformans. The 
genes of the enzymes of the reductive acetyl-CoA pathway are organised in one gene cluster. An open reading 
frame (orf7) is located between the genes coding for the subunits of CoFeSP. 
With the definition of the RACE protein family an alternative reductive activation mechanism 
for corrinoid enzymes in general (17) and for CoFeSP in particular, has been proposed. Like 
the activating enzyme of O-demethylases of A. dehalogenans the gene product of orf7 
belongs to COG3894 and contains a [2Fe2S] cluster binding motif at its N-terminus (17, 83). 
Dr. Jae-Hun Jeoung (Strukturbiologie / Biochemie, Humboldt Universität zu Berlin) was able 
to isolate the gene product for crystallisation and solved the structure by SAD-MAD 
techniques.  
The orf7 product is a homodimer; each monomer is composed of four domains (Figure 13A). 
A plant-ferredoxin like [2Fe2S] cluster is bound to the N-terminal domain (residues 1 – 94), 
which is connected by a long linker (residues 95 – 125) to the middle domain (residues126 – 
205). This domain is the contact interface responsible for the dimerisation of the monomers 
(Figure 13A) (102).  
The largest domain, the C-terminal domain (residues 206 – 631), shows a fold common in 
members of the ASKHA (acetate and sugar kinases/heat shock protein 70/actin) superfamily 
(47, 48). The domain is composed of two subdomains, I and II, consisting of a five-stranded 
β-sheet surrounded by three α-helices with βββαβαβα topology (Figure 13B) (102). A 
nucleotide-binding site is suggested to be located in a cleft between subdomain I and II. A 
phosphate ion associated with magnesium was modelled into the active site (Figure 13C) 
(102). 
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Figure 12: The overall structure of the gene product of orf7. (A) Shown is the homodimer in cartoon 
presentation. In the first monomer all domains are visible. The N-terminal domain is coloured in cyan with the 
[2Fe2S] cluster illustrated as spheres (iron atoms in red, sulfur in yellow). The middle domain is shown in blue 
and the big C-terminal domain with the ATP-binding site (ASKHA domain) in red. MgPO4 was modelled into 
the active site. The second monomer is coloured in grey. The N-terminal domain is disordered in this molecule. 
(B) Illustration of the subdomains I and II of the ASKHA domain (residues 207-630) with the for ASKHA 
family typical βββαβαβα topology. The α-helices are coloured in red, β-sheets in blue. (C) Nucleotide-binding 
site with Mg2+ and PO43- bound (spheres and stick model with Mg2+ in green, PO43- in yellow for phosphor and 
red for oxygen, water molecules are presented as red spheres). Residues in H-bonding distance are labelled. The 
figure was prepared from the PDB entry 3ZYY (102). 
Ensuing from the structure and the location of the open reading frame within the gene cluster 
of the proteins participating in the reductive acetyl-CoA pathway, a biochemical 
characterisation of the gene product appeared promising. The question, if a reductive activator 
of CoFeSP exists within the reductive acetyl-CoA pathway of C. hydrogenoformans and its 
characterisation as a member of the young RACE protein family, have been the driving force 
of this study.  
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4. Scope of the Study 
Electron transfer between proteins is at the heart of numerous biological processes including 
respiration and photosynthesis. To drive an energetically unfavourable electron transfer and 
keep it unidirectional, another energetic process such as an ATPase reaction needs to be 
coupled to it. This kind of energy transduction is found in the carbon and nitrogen cycle, in 
particular in the reductive activation of nitrogenase, radical-dependent β,α-dehydratases, the 
related benzoyl-CoA reductases, and different cobalamin-dependent methyltransferases (12, 
15, 17, 44, 53). General aspects of the reductive activation of corrinoid enzymes by a RACE 
protein were recently reported for the first time (16, 17, 73, 74), but a detailed characterisation 
of a RACE protein has had a long time in the coming. 
Aim of this work is the investigation of the gene product of orf7 found in the gene cluster 
coding for the enzymes of the reductive acetyl-CoA pathway of Carboxydothermus 
hydrogenoformans. The protein should be biochemically characterised with regard to its 
possible role in the reactivation of the inactive / oxidised corrinoid/iron-sulfur protein to 
prove that a RACE protein acts in this hydrogenic organism. The establishment of an 
activation assay demonstrating the need of ATP for interprotein electron transfer and the 
analysis of a possible complex formation as observed in nitrogenases and / or dehydratases by 
analytical gel filtration and isothermal titration calorimetry are one objective. The influence of 
a hypothetical complex formation on the single proteins and their cofactors should be 
considered and investigated by different spectroscopic methods. 
The biochemical characterisation of the putative RACE protein and its interactions with the 
target protein, CoFeSP, would be the first of its kind. The structural investigation of the 
putative activation complex is the main goal of this study to provide insights into the 
mechanism of activation of corrinoid containing proteins. 
Comparison with other activation systems is expected to reveal differences and / or common 
features of the three types of ATP-dependent activation systems found in the global carbon 
and nitrogen cycle and expand the understanding of how nature has devised different ways of 
translating the energy stored in the pyrophosphate bond of ATP to allow an energetically 
unfavourable electron transfer. 
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II. MATERIALS AND METHODS 
1. Chemicals 
All chemicals were of analytical purity grade (p.a.) and purchased from Applichem 
(Darmstadt, Germany), Merck (Darmstadt, Germany), Roth (Karlsruhe, Germany) and 
Sigma-Aldrich (Deisenhofen, Germany). 
Pure nitrogen (N2, 99.99 %) and nitrogen gas mixed with hydrogen (95 %N2/5 %H2) were 
provided by Air Liquide (Berlin, Germany). 
Enzymes used in microbiology were obtained from Thermo Fisher Scientific Biosciences 
GmbH (St. Leon-Rot, Germany) or New England Biolabs (Frankfurt/Main, Germany). 
Plasmid preparation kit, PCR product purification kit and Gel extraction kit were purchased 
from Thermo Fisher Scientific Biosciences GmbH as well as size markers for agarose and 
SDS gel electrophoresis. Bradford solution was supplied by BioRad (Munich, Germany). 
Chromatography columns and all materials used in the purification of proteins were 
purchased from GE Healthcare (Munich, Germany).   
Anaerobic reaction tubes (15 ml), EPA (Environmental Protection Agency) vials (20 ml), 
glass vials (2 ml), butyl and silicon septa and other anaerobic glass equipment were purchased 
from Supelco (Sigma-Aldrich) and OCHS (Bovenden / Lenglern, Germany). 
2. Working under Anoxic Conditions 
If not mentioned explicitly, all experiments were carried out under oxygen-free conditions in 
an anaerobic chamber (Coy Laboratory Products Inc., Michigan, USA) with a 95 % N2/ 5 % 
H2 atmosphere. ITC experiments were done under a N2 atmosphere inside a glove box (Braun, 
LabStar).  
Solutions and buffers for purification, activity assays and crystallisation were prepared in 
bottles with butyl rubber septa by evacuating and flushing with N2 (at least 5 cycles) at a 
vacuum gas line to remove dioxygen.  
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3. Molecular Biology 
3.1. Escherichia coli Strains 
For the cloning of genes Escherichia coli DH5α {F– .80 /lacZ/M15/(lacZYA-argF)U169, 
deoR, recA1, end A1,hsdR17(rk–, mk+), phoA, supE44,0–, thi-1, gyrA96, relA1} was used. 
3.2. Cloning and Mutagenesis of the orf7 Gene Product 
3.2.1. Deletion of the N-terminal Domain (Residues 1-100) 
For the deletion of the first 100 amino acids of the N-terminal domain of the putative 
reductive activator of CoFeSP (RACo) the PIPE (Polymerase incomplete primer extension) 
cloning method (103) modified by Dr. Martin Bommer (Strukturbiologie / Biochemie, 
Humboldt Universität zu Berlin) was used. The gene, lacking the base pairs of the first 100 
amino acids to be deleted, was amplified by PCR using Phusion DNA polymerase, the 
primers RACo100+_fwd and RACo100+_rev with specific overlaps for the pET28aTEV-
vector (Appendix Table 10) and genomic DNA of C. hydrogenoformans, respectively 
(Appendix Table 11). The conditions for the PCR are given in Appendix Table 12. The 
reaction was verified by loading a sample on a 1 % (w/v) agarose gel. The PCR product was 
purified and mixed with vector pET28a-TEV (prepared for PIPE cloning (103), provided by 
Dr. M. Bommer). After incubation on ice for five minutes, the plasmid was directly 
transformed into chemically competent E. coli DH5α cells. Positive clones were isolated and 
identified by DNA sequencing (Eurofins MWG Operon, Ebersberg) and named 
pPKCo28aTEV-Δ100. 
3.2.2. Active Site Mutants (QuickChange Method) 
The residues (D212, T215, D377, T380 and E404) considered to be responsible for binding of 
the nucleotide into the ATP binding pocket of RACo (Figure 13B) were mutated into 
alanines. For the insertion of point mutations the QuickChange Method (Stratagene Europe, 
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Amsterdam, Netherlands) was used. The plasmid pPKCoDuet1-TEV was amplified with the 
corresponding primers (Appendix Table 10) using Pfu DNA polymerase according to the 
manufacturer´s protocol. Mutagenesis primers and PCR conditions are listed in Appendix 
Table 13 and Table 14. Positive clones were isolated and identified by DNA sequencing 
(Eurofins MWG Operon, Ebersberg, Germany). 
3.2.3. Mutation of Ser398 by Combining PIPE Cloning and QuickChange Method 
The gene orf7 coding for RACo was amplified using the primer orf7-fwd and S398X-rev in a 
first PCR. The PCR product was used in a second PCR reaction with primer orf7-rev and a 
forward primer carrying the point mutation for S398. The primers R_S398X-fwd and 
R_398X-rev contained the specific overlaps for the pET28a-TEV vector used for PIPE 
cloning (103) (Appendix Table 10). The same conditions were chosen for both PCRs 
(Appendix Table 15 and Table 16). The product of the second reaction was mixed with vector 
pET28a-TEV and subsequently treated as described in section 3.1.1.  
3.3. Cloning and Mutagenesis of CoFeSP 
3.3.1. Deletion of Entire Domains of CfsA 
For the deletion of the entire C- or N-terminal domain of the large subunit CfsA of CoFeSP 
(ΔN60-CoFeSP and) the PCR:Religate:Transform method of Dr. Martin Bommer 
(Strukturbiologie / Biochemie, Humboldt Universität zu Berlin) was used (104). The template 
pPKCD was amplified by PCR (Appendix Table 18 and Table 19) with the primers given in 
Appendix Table 17. The purified linear vector was incubated with phosphokinase for 30 min 
at 37 °C and then re-ligated for 10 min at room temperature using T4 DNA ligase. The 
ligation product was further purified and transformed into chemically competent cells. To 
identify positive clones plasmid samples of pPKCD_MC (ΔN60-CoFeSP) and pPKCD_NM 
(ΔC128-CoFeSP) were sent for sequencing (Eurofins MWG Operon, Ebersberg, Germany).  
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3.3.2. Site Directed Mutagenesis of Cysteines Coordinating the [4Fe4S] Cluster 
The exchange of single cysteines coordinating the four irons of the [4Fe4S] cluster of CoFeSP 
was performed using the QuickChange protocol from Stratagene (Stratagene Europe, 
Amsterdam, Netherlands) with pPKCD as template. The primers and conditions of the PCR 
are listed in Appendix Table 17, Table 20 and Table 21, respectively. Positive constructs were 
identified by sequencing (Eurofins MWG Operon, Ebersberg, Germany) for the residues 
C20A, C20P and C25P. 
3.4. Agarose Gel Electrophoresis 
For the isolation of DNA or the analysis of PCR products 1 % (w/v) agarose gels containing 
GelRedTM (Biotium Inc.) were prepared routinely. Samples were mixed with 6-fold Loading 
Dye and loaded onto gels. DNA marker (Thermo Fisher Scientific Biosciences GmbH) was 
applied. Electrophoresis procedure was carried out in a horizontal gel system (PEQLAB 
Biotechnologie GmbH, Erlangen) at 90 V. 
3.5. Transformation of Escherichia coli Competent Cells 
Chemically competent cells of E. coli were transformed by adding 1 µL of plasmid DNA (20–
400 ng/µL) to 200 µL cells refrigerated on ice. After incubation for 30 min on ice the samples 
were exposed to 42 °C for 45 s and subsequently chilled on ice for 10 min. 900 µL of LB 
medium were added and the samples were incubated at 37 °C while shaking for one hour. The 
samples were centrifuged at 14,000 g, supernatant was discarded and the pellets were 
resuspended in 100 µL LB medium. The transformed cells were plated onto LB agar plates 
containing the corresponding antibiotics or grown as overnight cultures in LB medium. 
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4. Expression and Purification of Proteins  
4.1. Heterologous Expression 
Genes were routinely expressed in E. coli strain BL21(DE3) with genotype E. coli {F– ompT 
hsdSB(rB– mB–) gal dcm (DE3)}. Composition of the modified Terrific Broth (mTB) medium 
(93) with the antibiotics used for protein expression is shown in the following tables. 
Table 1: Composition of expression medium. 
 
 
 
 
 
 
 
Table 2: Antibiotics used for expression. 
4.1.1. Expression of RACo (Variants) 
The plasmids pPKCoDuet1-TEV or pPKCo28a-TEV and all modified vectors of RACo were 
transformed into the E. coli expression strain BL21(DE3). All strains were cultivated by 
shaking at 37 °C in mTB medium (93) supplemented with 0.3 mM FeSO4, 0.3 mM Na2S and 
the appropriate antibiotics. Gene expression was induced by the addition of 0.5 mM IPTG at 
an OD600 of 0.6 and 0.3 mM FeSO4 and 0.3 mM Na2S were added to the culture which was 
further cultivated at 32 °C. Six hours after induction cells were harvested by centrifugation at 
7,000 rpm and 12 °C. Cell pellets were stored at –20 °C until use. 
The RACo variant missing the [2Fe2S] cluster domain (Δ100-RACo) was expressed as 
described above without addition of iron and sulfur sources. 
 mTB medium  
12 g/L 
24 g/L 
10 mL/L 
Tryptone 
Yeast extract 
Glycerol 
Antibiotic Stock concentration Final concentration in the media 
Carbenicillin (Cb) 50 mg/mL in ddH2O 50 µg/mL 
Kanamycin (Km) 50 mg/mL in ddH2O 50 µg/mL 
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4.1.2. Expression of CoFeSP (Variants) 
All plasmids coding for CoFeSP and CoFeSP variants (pPKCD, pPKCD_MC, pPKCD_NM 
and pPKCD_C25P) were transformed into E. coli BL21(DE3). The strains were cultivated by 
shaking at 37 °C. 0.2 mM FeSO4, 0.2 mM Na2S and the appropriate antibiotics were added to 
the mTB media (93). When an OD600 of 0.7 was reached 0.4 mM IPTG was added to induce 
the expression and the culture was supplemented with 0.3 mM FeSO4 and 0.3 mM Na2S. The 
culture was further cultivated at 32 °C and harvested 8 h after induction as described above. 
The strain harbouring the plasmid pPKacsCD_MC (ΔN60-CoFeSP) was cultivated without 
supplementation of iron or sulfur. 
4.2. Protein Purification 
All protein purification steps were performed inside a glove box (model B, COY Laboratory 
Products Inc., Michigan, USA) under an atmosphere of 95 % N2 / 5 % H2. Δ100-RACo was 
purified aerobically but buffer exchange was performed under anoxic conditions. 
Homogeneity and concentrations of purified proteins were routinely analysed by SDS-PAGE 
(105) and the Bradford method (106) (Materials and Methods 5.1 and 5.2). 
4.2.1. Purification of RACo, RACo Mutants and Δ100-RACo 
4.2.1.1. Purification of RACo without Affinity Tag (Native Purification) 
Table 3: Buffers used in native purification of RACo. 
 
 
 
 
 
 
RACo purification without affitnity tag 
Buffer A 50 mM Tris/HCl, pH 8.0 
Buffer B 50 mM Tris/HCl, pH 8.0 
1 M NaCl 
Buffer C 50 mM Tris/HCl, pH 8.0 
1 M (NH4)2SO4 
Buffer D 50 mM Tris/HCl, pH 8.0 
150 mM NaCl 
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The cell pellet was thawed on ice and resuspended in buffer A containing catalytic amounts of 
DNase I and lysozyme. The cell suspension was stirred for 10 minutes at room temperature. 
Cells were further disrupted by sonication using an ice-cooled rosette cell (Branson sonifier, 3 
cycles of 5 min sonication, 50 % duty cycle). The suspension of broken cells was cleared 
from cell debris by ultracentrifugation at 35,000 rpm and 8 °C for 1 h. The supernatant was 
loaded onto DEAE sepharose material (50 mL, GE Healthcare) equilibrated in buffer A. After 
washing with buffer A, the protein was eluted with a linear gradient over 500 mL from 0 – 
1 M NaCl using buffer B. Red coloured fractions were pooled and suspended in ammonium 
sulphate to a final concentration of 1 M. The suspension was stirred for 30 min at room 
temperature and centrifuged for 15 min at 12,000 rpm and 12 °C. The supernatant was applied 
to a phenyl sepharose column (25 mL, GE Healthcare) equilibrated in buffer C. After 
washing, the column was developed with a linear gradient of 1 – 0 M ammonium sulfate. 
Fractions containing RACo were pooled and concentrated to a volume less than 5 mL using a 
Vivaspin 70 spin concentrator (50 kDa molecular weight cutoff; Vivascience GmbH) 
equipped with a rubber-sealed screw cap followed by load of the concentrate onto a 
SuperdexTM 200 prep-grade gel filtration column (120 mL, GE Healthcare) equilibrated in 
buffer D. Protein fractions corresponding to the size of the RACo homodimer were collected 
and concentrated. A sample was taken for SDS-PAGE analysis (Materials and Methods 5.1), 
iron quantification (Materials and Methods 5.3) (107) and concentration determination by 
Bradford (Materials and Methods 5.2). The protein was frozen in glass vials equipped with a 
butyl-rubber septum in liquid nitrogen and stored at –80 °C.  
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4.2.1.2.Purification of RACo, RACo Mutants and Δ100-RACo by Removable Affinity Tag 
Table 4: Purification buffers of the affinity tag purification of RACo. 
 
 
 
 
 
 
 
 
 
 
 
Cell free soluble supernatant was prepared as described above. The supernatant was loaded 
onto Ni-SHP material (5 mL, GE Healthcare) equilibrated in buffer B. The column was 
washed with buffer B and subsequently developed with a 450 mL linear gradient from 20 to 
250 mM imidazole (buffer C). Coloured fractions were pooled and loaded onto a Source 30Q 
or Q-Sepharose column (30-50 mL, GE Healthcare) equilibrated in buffer A. RACo was 
eluted by applying a linear salt gradient from 0 to 1 M using buffer D. The His6 tag was 
removed by overnight incubation at room temperature with His6-tagged TEV protease in the 
same buffer supplemented with 5 mM β-mercaptoethanol. To separate RACo from TEV 
protease the mixture was applied to the Ni-SHP material. The flow-through containing RACo 
was pooled and concentrated to a volume less than 5 mL using an Amicon Ultra-15 30 K spin 
concentrator (Millipore). The concentrate was loaded onto a 120 mL SuperdexTM 200 prep-
grade gel filtration column (GE Healthcare) equilibrated in buffer E. Fractions containing the 
RACo dimer were collected and concentrated. A sample was taken for SDS-PAGE analysis. 
The iron content was measured via the Fish method and the concentration was determined 
(Materials and Methods 5.1, 5.2 and 5.3). Aliquots of 100 µL were frozen in glass vials 
equipped with butyl rubber septa in liquid N2 and stored at –80 °C. 
RACo purification 
Buffer A 50 mM Tris/HCl, pH 8.0 
Buffer B 50 mM Tris/HCl, pH 8.0 
200 mM NaCl 
20 mM Imidazole 
Buffer C 50 mM Tris/HCl, pH 8.0 
200 mM NaCl 
250 mM Imidazole 
Buffer D 50 mM Tris/HCl, pH 8.0 
1 M NaCl 
Buffer E 50 mM Tris/HCl, pH 8.0 
150 mM NaCl 
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4.2.1.3.Purification of CoFeSP, ΔN60-CoFeSP, ΔC128-CoFeSP and C25P-CoFeSP 
Table 5: Purification buffers used in the purification of CoFeSP. 
 
 
 
 
 
 
 
 
Preparation of soluble supernatant was done as described in Materials and Methods 4.1.1. The 
soluble fraction was loaded onto a Q-Sepharose column (50 mL, GE Healthcare), which was 
equilibrated in buffer A. The column was washed with buffer A and developed with a 450 mL 
linear gradient from 0 to 0.8 M NaCl (buffer B). Fractions containing CoFeSP were pooled, 
suspended in a 1 M ammonium sulphate solution and incubated for 30 min. The suspension 
was applied to phenyl sepharose material (25 mL, GE Healthcare) equilibrated in buffer C. 
After washing, CoFeSP was eluted applying a linear gradient from 1 to 0 M ammonium 
sulphate. Fractions containing equimolar amounts of large and small subunit were pooled and 
reconstituted by adding equimolar amounts of hydroxocobalamin. The solution was incubated 
overnight at 25 °C. Reconstituted CoFeSP was further purified using a Source 30Q column 
(30 mL, GE Healthcare) equilibrated in buffer A. CoFeSP was eluted by a linear increasing 
concentration from 0 to 0.8 M NaCl (buffer B). As a last purification step, size exclusion 
chromatography was carried out using a SuperdexTM 200 prep-grade gel filtration column 
(120 mL, GE Healthcare) equilibrated in buffer D. The protein was analysed by SDS-PAGE 
and concentration was determined by the Bradford method (Materials and Methods 5.1 and 
5.2). Aliquots of 100 µL were frozen in glass vials equipped with butyl rubber septa in liquid 
N2 and stored at –80 °. 
CoFeSP purification 
Buffer A 50 mM Tris/HCl, pH 8.0 
Buffer B 50 mM Tris/HCl, pH 8.0 
1 M NaCl 
Buffer C 50 mM Tris/HCl, pH 8.0 
1 M (NH4)2SO4 
Buffer D 50 mM Tris/HCl, pH 8.0 
150 mM NaCl 
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4.2.1.4.Purification of CoFeSP used for ATPase Activity Measurements 
CoFeSP used in the ATPase activity assay was prepared as communicated by Sebastian Götzl 
(Strukturbiologie / Biochemie, Humboldt Universität zu Berlin).  
First, the small subunit of CoFeSP, CfsB, was purified from 10 g E. coli BL21(DE3) / 
pPKacsD cells in three chromatographic steps as described before for complete CoFeSP. 13 g 
cells transformed with the plasmid pPKacsC were resuspended in 50 mM Tris/HCl, pH 8.0 
containing 2 mM DTT. After 15 min sonication, the cell lysate was centrifuged for 1.5 h at 
35,000 rpm and 10 °C. The supernatant was discarded and the pellet containing the insoluble 
large subunit CfsA was successively washed with Tris-buffer containing 1 mM EDTA and 
then centrifuged until the supernatant had become colourless. The washed pellet was 
resuspended in 10 mL Tris-buffer containing 1 mM DTT and stored at –80 °C. 18 mg of pure 
CfsB in 2 mL 50 mM Tris-buffer containing 100 µM hydroxocobalamin were mixed with 
2 mL of the pellet suspension. The mixture was diluted 2-fold with Tris-buffer containing 4 M 
urea and incubated for 15 min at 25 °C. After centrifugation at 12,000 rpm for 10 min, the 
supernatant was diluted and concentrated to decrease the concentration of urea to less than 
0.1 M. 200 µM hydroxocobalamin were added and after 45 min incubation at room 
temperature size exclusion chromatography was performed (SuperdexTM 200 prep-grade, 
120 mL, GE Health Care, equilibrated in buffer D). Fractions corresponding to the CoFeSP 
heterodimer were combined, concentrated, analysed (Materials and Methods 5.1 and 5.2) and 
frozen in liquid nitrogen. 
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5. Analytical Methods 
5.1. SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
To analyse protein samples according to their size, SDS-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) described by Laemmli (105) was used. 
Table 6: Composition of SDS-Polyacrylamide gels, solutions and buffers used for SDS-PAGE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Samples were mixed with SDS loading buffer and boiled at 100 °C. Unstained protein 
molecular weight marker (Thermo Fisher Scientific Biosciences GmbH) served as a size 
standard. For electrophoresis, a voltage of 80 V was applied to the gel which was increased 
after 20 min to 120 V. Gels were stained by incubation in warm staining solution followed by 
destaining solution for several hours.  
 
Resolving gel  Stacking gel  
12 or 15 % (w/v) Acrylamide 6 % (w/v) Acrylamide 
375 mM Tris/HCl, pH 8.8 125 mM Tris/HCl, pH 6.8 
0.1 % (w/v) SDS 0.1 % (w/v) SDS 
0.08 % (w/v) TEMED 0.08 % (w/v) TEMED 
0.05 % (w/v) APS 0.05 % (w/v) APS 
 
Staining solution 
  
Destaining solution 
 
0.025 % (w/v) Coomassie Brilliant 
Blue G250 
10 % (v/v) Acetic acid 
10 % (v/v) Acetic acid   
    
4xSDS sample buffer  10xSDS running buffer 
200 mM Tris/HCl, pH 6.8 1.92 M Glycine 
0.4 M DTT 248 mM Tris 
8 % (w/v) SDS 1 % (w/v) SDS 
40 % (v/v) Glycerol   
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5.2. Determination of Protein Concentration 
The concentration of proteins was determined by the method described by Bradford (106). 
Bradford and BSA solutions used for the preparation of standard curves were supplied by 
BioRad. In the case of the RACo variant Δ100 the protein concentration was calculated via 
the absorption at 280 nm applying the calculated theoretical extinction coefficient 
(ε280 = 31,860 M-1cm-1) (108). 
5.3. Iron Quantification 
To quantify protein bound iron the method described by Fish (107) was applied.   
100 µL of a RACo sample was mixed with 100 µL 1 % (w/v) HCl and incubated for 10 min 
at 80 °C. When cooled down to room temperature, 500 µL 7.5 % (w/v) ammonium acetate, 
100 µL 4 % (w/v) ascorbic acid and 100 µL 2.5 % (w/v) SDS and 100 µL 1.5 % (w/v) ferene 
were added sequentially. The reaction mixture was centrifuged at 14,000 rpm for 10 min and 
the absorbance at 593 nm was measured against water. 
The amount of iron within the protein sample was calculated from a standard curve obtained 
by measuring known iron concentrations between 2 and 20 µM Fe.  
5.4. Analytical Size Exclusion Chromatography 
For the investigation of the complex formation between RACo and CoFeSP and their variants 
analytical size exclusion chromatography was performed using either a SuperdexTM 200 prep-
grade gel filtration column (dimension 16 × 600 mm, GE Healthcare) or a Superdex S 150/5 
column (dimension 5 x 150 mm, GE Healthcare) inside a glove box. Equimolar 
concentrations of the proteins (generally 25 or 45 µM) were incubated 10 min at room 
temperature and injected onto the gel filtration column equilibrated in 50 mM Tris/HCl, pH 
8.0, 150 mM NaCl and additives as following. 
To test the influence of nucleotides on complex formation 5 mM ATP or 5 mM ADP in the 
presence of 50 mM MgCl2 were added to the protein sample and buffer. Redox-state 
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dependent complex formation of RACo and CoFeSP was determined by pre-incubation of 
RACo with the different redox states of CoFeSP (Co(II)-CoFeSP, Co(I)-CoFeSP and CH3-
Co(III)-CoFeSP), respectively, before load onto the column. To prepare Co(I)-CoFeSP the 
protein was incubated at least for 20 minutes with 1 mM Na-dithionite (DT) and the running 
buffer was supplemented with 1 mM DT. CH3-Co(III)-CoFeSP was prepared by 
reconstitution of CoFeSP during purification with methyl-cobalamin. Individual peak 
fractions from each gel filtration experiment were collected and analysed by SDS-PAGE 
(Materials and Methods 5.1). The programme ImageMaster™ 2D Platinum v7.0 (GE 
Healthcare) was used for densitometry analysis of the SDS gels.  
The elution volumes of the peaks were transformed into molecular weights using a standard 
curve (Appendix Figure 52) calculated from known standard proteins in the running buffer: 4 
mg∕mL lactate dehydrogenase (140 kDa), 4 mg∕mL conalbumin (75 kDa), 4 mg∕mL ovalbumin 
(43 kDa), and 4 mg∕mL ribonuclease (13.7 kDa). 
5.5. Isothermal Titration Calorimetry 
The dissociation constants of the complex between RACo and Co(II)-CoFeSP, Δ100-RACo 
and Co(II)-CoFeSP and the RACoS398-mutants and Co(II)-CoFeSP were determined by ITC. 
ITC experiments were performed at 25 °C inside a glove box (LabStar, Braun) using a VP-
ITC Micro Calorimeter (Microcal LLC). Storage buffers of the proteins were exchanged to 
50 mM Tris/HCl, pH 8.0 containing 150 mM NaCl using SuperdexTM 200 prep-grade gel 
filtration column to remove remaining reducing agent from purification. Experiments were 
performed with 100 - 150 µM of RACo, RACoΔ100 or RACo-S398A or C, and 10 – 15 µM 
Co(II)-CoFeSP. Data were processed with supplier´s software assuming a one-site binding 
model (Microcal Origin). 
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6. Enzyme Activity Assay 
6.1. NTPase Activity Assay 
6.1.1. Malachite Green Assay 
ATPase activity was determined by detecting the amount of inorganic phosphate (Pi) released 
during ATP hydrolysis by RACo using a modified malachite green-ammonium molybdate 
(MGAM) assay (109). The released Pi can be quantified by the absorbance of the 
phosphomolybdate-malachite green complex at 630 nm. 
Table 7: Stock solutions and buffer of the MGAM-ATPase assay. 
Stock solutions   Buffer A  
A 0.0812 % (w/v) Malachite green  100 mM Tris/HCl, pH 7.6 
B 2.32 % (w/v) Polyvinylalcohol  150 mM KCl 
C 5.72 % (w/v) Ammonium molybdate  10 mM MgCl2 
D  ddH2O    
E 34 % (w/v) Sodium citrate    
mix 2A + 1B +1C + 2D    
The MGAM solution was prepared freshly prior to use by mixing the stock solutions in the 
ratios given in Table 7. The dark brown solution turned golden yellow after approximately 
30 min incubation at room temperature. The assay was performed under oxic conditions. 
Generally, 10 or 15 µM RACo were incubated with 5 mM Mg-ATP in buffer A at different 
temperatures (RT, 37°C, 45°C, 50°C and 55°C, respectively). A complex sample was 
prepared by mixing 10 µM RACo and 10 µM CoFeSP. Every 15 or 20 min a sample of 25 µL 
was taken, diluted with 75 µL ddH2O and 800 µL of the MGAM-mix were added. The 
calorimetric reaction was quenched with 100 µL Na-citrate and the assay mix was incubated 
for 15 min at room temperature before the absorption at 630 nm was measured. The amount 
of released phosphate by RACo was calculated from a standard curve (Appendix Figure 50) 
prepared from 1 to 9 nmol KH2PO4 plotted against the absorption at 630 nm. The absorbance 
of the sample was corrected by subtracting the absorbance of the corresponding control 
sample without protein. 
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One unit of activity (U) was defined as one µmol Pi released per minute. The specific 
activities of enzyme were designated in mU (mg protein)–1 (equation 4).  
 
1mU =1
∆nPi nmol[ ]
min× mgPr otein
     (4) 
6.1.2. Coupled ATPase Assay 
Table 8: Reaction mix and buffer used in the coupled ATPase activity assay. 
Reaction mix   Buffer A  
9.9 U LDH  100 mM HEPES, pH 7.5 
6.8 U PK  150 mM K-acetate / KCl  
2 mM Phosphoenolpyruvate   10 mM Mg-acetate / MgCl2 
0.16 mM NADH    
0.2 - 2 µM Protein    
Beside the MGAM ATPase assay, a coupled assay with pyruvate kinase (PK) and lactate 
dehydrogenase (LDH) was used to follow the hydrolysis of ATP catalysed by wild type and 
the active site mutants of RACo (equation 5). The steady state kinetic constants, Km and kcat, 
were determined with this method (110). 
    (5) 
The reaction mixture was prepared in buffer A and contained either 200 nM or 2 µM of the 
wild type or the mutants of RACo. To test the influence of the presence of CoFeSP on the 
ATPase activity of RACo, the two proteins (2 µM each) were incubated for 10 minutes before 
the reaction was started. After blanking 0.16 mM of NADH was added and the reaction was 
initiated by addition of ATP. The consumption of NADH by LDH, corresponding to the 
ATPase activity of the enzyme, was followed spectroscopically by the decrease of absorption 
at 340 nm at 25 °C (Agilent 8453 photodiode array spectrophotometer with Peltier element). 
By varying the concentration of ATP from 0-9 mM the steady-state kinetic constants Km and 
Vmax were determined by applying the Michaelis-Menten equation (GraFit 5). One unit of 
ATPase activity was defined as one µmole of ADP produced per minute (equation 6) and was 
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calculated from the consumption of NADH by LDH using the extinction coefficient of 
NADH at 340 nm (ε340 = 6220 M-1cm-1). 
 
1mU =
dn(ADP)
min× mgPr otein
 
 
 
 
 
 =
∆n(NADH) nmol[ ]
min× mgPr otein     (6)
 
6.2. ATP-Dependent Reductive Activation Assay 
Table 9: Buffer of the reductive activation assay. 
Buffer A  
100 mM Tris/HCl, pH 8.0 
150 mM KCl 
10 mM MgCl2 
2 mM DTT 
The electron transfer assay was performed at a constant temperature of 25 °C under anoxic 
conditions inside a glove box using a photospectrometer equipped with a Peltier element 
(Agilent 8453 diode array photometer). The reaction mixtures contained equimolar amounts 
of the two proteins (usually 2.5 µM) in buffer A. The reaction was performed in 1 cm path-
length cuvettes sealed with a butyl rubber septum and slight N2 overpressure was applied. The 
reduction of the activator by DTT was followed by the decrease of absorption of characteristic 
bands for the [2Fe2S] cluster at 350, 410 and 460 nm. The baseline was defined when 
reduction of RACo was complete. Addition of ATP by a syringe initiated the reduction of 
Co(II)-CoFeSP to Co(I)-CoFeSP. The development of active Co(I)-species was followed by 
monitoring the increase of absorption at 390 nm and the decrease at 475 nm (94). Spectra 
were recorded every 5 – 10 s. 
The electron transfer assay was also performed with the active sites mutants of RACo 
applying concentrations of 10 µM of both proteins in the reaction mixture as described above 
for the wild type. 
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7. Spectroscopy 
7.1. UV-VIS Spectroscopy 
UV-vis spectra of RACo wild type and mutants as well as of CoFeSP were measured on an 
Agilent 8453 photodiode array spectrophotometer. All measurements were performed 
anaerobically at 25 °C using quartz cuvettes with 1 cm path length. The UV-vis spectrum of 
4 μM RACo (as-isolated) in 50 mM Tris/HCl, pH 8.0, 150 mM NaCl was recorded. To obtain 
reduced RACo, 2 mM dithiothreitol were added and complete reduction was achieved after 
approximately 20 min. 
7.2. Resonance Raman Spectroscopy 
Resonance Raman Spectroscopy was performed in cooperation with Wiebke Meister and 
Prof. Dr. Peter Hildebrandt (Institut für Chemie, Technische Universität Berlin) to investigate 
the influence of complex formation on the environment of the cofactors. Results of this 
cooperation have been published (111) . 
7.2.1. Sample Preparation for Resonance Raman Spectroscopy 
Samples were prepared anaerobically by concentrating the stock protein solutions (in 50 mM 
Tris/HCl, pH 8.0, 150 mM NaCl) to a final concentration of 1 mM. Vivaspin 500 
concentrators with 30,000 MWCO for CoFeSP variants and 50,000 MWCO for RACo 
variants were used. When both protein variants were mixed, the samples were incubated for 
15 min before concentrated using Vivaspin 500 spin concentrators with 100,000 MWCO 
(Sartorius stedim biotech GmbH). Reduced Co(I)-CoFeSP was prepared by adding 0.5 M DT 
to the sample.  
A 3 μL drop of the sample solutions was placed onto a quartz holder and directly immersed in 
liquid nitrogen. The holders were subsequently transferred into the cryostat of the device. 
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7.2.2. Resonance Raman Spectroscopy of RACo and CoFeSP Variants 
Measurements were carried out using the 413 nm line of a Krypton ion laser (Coherent 
Innova 300c) connected to a single-stage spectrograph (Jobin Yvon, LabRam 800 HR) and a 
liquid-nitrogen-cooled back-illuminated CCD detector. To focus the laser beam a Nikon 20× 
objective (N.A. 0.35) in a working distance of 20 mm was used. A laser power of 5 mW was 
applied to the sample and acquisition times ranged from 60 to 150 s according to the spectral 
quality of the samples. Signal / noise ratio was improved by averaging 4–30 single spectra. 
RR spectra were measured at approximately 80 K (Resultec/Linkam cryostat) under constant 
nitrogen stream on the sample. 
7.2.3. Electron Paramagnetic Resonance Spectroscopy (EPR) 
EPR was performed in cooperation with Dr. Friedhelm Lendzian and Prof. Dr. Peter 
Hildebrandt (Institut für Chemie, Technische Universität Berlin). Results have been published 
(111) . 
7.2.4. Sample Preparation for EPR Spectroscopy 
EPR samples of RACo and Co(II)-CoFeSP were prepared by dilution of the protein stock 
solutions to a final concentration of 300 µM in 50 mM Tris/HCl, pH 8.0, 150 mM NaCl. A 
complex sample was prepared by mixing both proteins in the presence of 300 mM DTT 
followed by incubation for 15 min. Co(I)-CoFeSP was obtained by incubation of the protein 
with 300 mM DT. The samples were transferred into EPR sample tubes. The tubes were gas-
tight sealed and exported from the glove box and immediately frozen in liquid nitrogen.  
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7.2.5. EPR Spectroscopy of CoFeSP and the RACo:CoFeSP Complex 
EPR measurements were performed at 9.3 GHz on a Bruker EMX Plus spectrometer 
connected to a high sensitivity cylindrical mode resonator (Bruker Super-high-Q-cavity ER 
4122 SHQE). The spectra were recorded at a field modulation of 100 kHz and 10 G. 
Temperature was set with a cryostat (Oxford ITC4, Oxford ESR 900 helium flow) to 100 K to 
detect Co(II) and / or reduced [2Fe2S] and to 10 K for reduced [4Fe4S]. Background spectra 
of each set of experimental conditions were measured and used as correction for the protein 
spectra. 
8. Redox Titration of RACo, CoFeSP and the RACo:CoFeSP Complex 
Redox titrations were performed in the laboratory of Prof. Dr. Peter Hildebrandt together with 
Dr. Friedhelm Lendzian (Institut für Chemie, Technische Universität Berlin).  
The buffer of the protein stock solutions was exchanged to 100 mM CAPSO, pH 9.5 using 
PD10 columns (GE Healthcare) to extend the negative potential range of sodium dithionite. 
RACo, Co(II)-CoFeSP and RACo-Co(II)FeSP-complex samples with a final concentration of 
130 µM in 2 mL buffer were prepared. The samples were evacuated and flushed with argon in 
order to remove hydrogen.   
The titration was performed inside a glove box under an atmosphere of nitrogen with oxygen 
concentrations below 10 ppm (VAC 101965 OMNILAB). A mediator mix covering a 
midpoint potential range from +80 to -550 mV was prepared by mixing 50 µM of phenazine 
methosufate, toluidine blue, methylene blue, indigocarmine, anthrachinone-2-sulfonate, 
phenosafranine, safranine T, deiquat, methylviologen and triquat, respectively,. The mediator 
mix was resuspended in the sample and DT was added stepwise. Potentials were measured 
with an Ag-AgCl electrode. Equilibrium was reached when the measured potential drift was 
less than 2 mV per minute. For each potential exactly 80 µL of the protein solution was 
transferred to an EPR tube. The tube was sealed and extroduced from the glove box. The 
samples were immediately frozen and stored in liquid nitrogen. EPR spectra were measured 
according to Materials and Methods 7.3.2. and the intensities of every species were plotted 
against the corresponding potentials. The potentials measured with the Ag-AgCl electrode 
were corrected by the potential of the redox electrode determined with quinhydrone. Data 
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have been fitted to a single-electron process (z = 1) according to the Nernst equation where 
Eθred is the standard half cell reduction potential, R= 8.314 J K-1 mol-1 is the universal gas 
constant and F = 9.648×104 C mol-1 is the Faraday constant (equation 7). 
 
ERed = E
Θ
red −
RT
zF
ln
cRed
cOx       (7)
 
9. Crystallisation  
9.1. Crystallisation of the RACo:CoFeSP Complex 
All crystallisation experiments were set up under anoxic conditions with a 95 % N2/ 5 % H2 
atmosphere and oxygen concentrations below 1 ppm. The sitting drop vapour diffusion 
method was used for initial screening. Crystals were obtained from various screens appearing 
after a period of several months. All crystallisation conditions contained PEG 3350 and low 
salt concentrations. The crystals were transferred into cryoprotective buffer consisting of the 
reservoir solution and 10 % (v/ v) 2R,3R butanediol as cryoprotectant and flash cooled with 
liquid nitrogen. 
9.2. Data Collection 
Diffraction data were collected on beamlines 14.1 and 14.2 at the Helmholtz Zentrum Berlin 
(BESSYII) (112). Collected data were indexed and processed with X-ray Detector Software 
(XDS) (113) to a resolution of 2.5 Å. The crystal belonged to space group P1 with cell 
parameters a = 67.13, b = 128.18, c = 163.37, α = 77.61, β = 82.25, γ = 88.76. Calculation of 
the Matthew’s coefficient suggested a solvent content of 43 % and four molecules per 
asymmetric unit using a molecular size of 150 kDa per complex molecule. 
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9.3. Structure Determination, Refinement and Graphical Representation 
Phase determination was carried out by molecular replacement with structures of the single 
compounds of the complex, using RACo (PDB 3ZYY) (102) and CoFeSP (2YCL) (94) as 
search models. Initially, CoFeSP was used as a search model and the RACo structure was 
applied as a secondary search with the fixed solution from the first replacement using either 
Phaser of the CCP4i programme suite (114) or the Phenix packages (115). A model of the 
structure was built according to the observed electron density map and the sequence of the 
single proteins using the programme COOT (116). The structure was further refined with 
REFMAC5 (CCP4i) (114) and REFINE of the Phenix package (115) to final Rwork and Rfree of 
20.4 % and 25.6 %, respectively. Statistics for refinement are summarised in Appendix Table 
22. Graphical presentations of the final model and of all other protein structures showed in 
this thesis were created using the programme PyMol (117). 
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III. RESULTS AND DISCUSSION 
1. Cloning, Mutagenesis and Expression  
1.1. RACo 
The gene CHY_1224, an uncharacterised gene (orf7) located in the gene cluster coding for the 
structural genes of the reductive acetyl-CoA pathway (Figure 11), was amplified by PCR 
from the genomic DNA of Carboxydothermus hydrogenoformans Z-2901 and cloned into 
pETDuet1 and pET28a vector (Novagen) by Dr. Jae-Hun Jeoung (Strukturbiologie / 
Biochemie, Humboldt Universität zu Berlin). The resulting constructs were named 
pPKCoDuet1 and pPKCo28a, respectively. The construct pPKCoDuet1 was first used for 
native purification. Protein purified from pPKCo28a contained a non-cleavable His-tag.  
To simplify the purification as well as to increase the purity of RACo and to have a cleavable 
affinity tag, the plasmids pPKCoDuet1 and pPKCo28a were modified by inserting a cleavage 
site for Tobacco Etch Virus (TEV) protease as described in Materials and Methods 3.2. These 
constructs were used for purification as well as templates for mutagenesis. The active site 
mutants D212, D377, E404, and T380 were created from pPKCoDuet1-TEV.  For RACo∆100 
and the S398 mutants pPKCo28aTEV served as template. All mutated constructs were 
obtained as described (Materials and Methods 3.2) and the successful insertion of the desired 
mutation(s) was confirmed by sequencing (Eurofins MWG Operon, Ebersberg, Germany). 
Plasmids were transformed into Escherichia coli BL21(DE3) and expressed as described in 
Materials and Methods 3.5 and 4.1.1. 
1.2. CoFeSP 
The plasmid pPKCD was kindly provided by Sebastian Götzl (Strukturbiologie / Biochemie, 
Humboldt Universität zu Berlin) and was used as template for modifications and mutations of 
CoFeSP. The deletion variants ΔN60-CoFeSP and ΔC128-CoFeSP as well as C25P-CoFeSP 
were obtained from the original plasmid as described in Materials and Methods 3.3. All 
constructs were confirmed by sequencing (Eurofins MWG Operon, Ebersberg, Germany). 
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CoFeSP and its variants were expressed in Escherichia coli BL21(DE3) cells (see Materials 
and Methods 3.5 and 4.1.2). 
2. Purification of Proteins 
2.1. Purification of RACo, RACo Mutants and Δ100-RACo 
2.1.1. Purification without Affinity Tag 
The reductive activator of CoFeSP was purified natively in a three-step purification. Ion-
exchange chromatography (IEC), followed by hydrophobic interaction chromatography (HIC) 
and size exclusion chromatography (SEC) were applied sequentially.  
In a standard native purification, 50 – 80 mg of RACo were obtained from 20 – 30 g cells 
(wet weight). According to the primary structure of the orf7 gene product, the dimeric protein 
binds one [2Fe-2S] cluster per monomer. The amount of protein bound iron ranged from 50 to 
71%.  
2.1.2. Purification Using a Removable Affinity Tag 
Wild type and the different variants of RACo, e.g. RACo∆100, the active site mutants and 
S398A/C were isolated based either on a two-step (mutants D121A-, D377A-, E404A- and 
S398A/C-RACo) or three-step purification including immobilised metal affinity 
chromatography (IMAC) and size-exclusion chromatography (SEC). For wildtype-RACo a 
three-step purification including affinity chromatography (IMAC), ion-exchange 
chromatography (IEC) and size-exclusion chromatography (SEC) was performed (Appendix 
Figure 49). Due to the removable His6-tag an overnight incubation of fractions containing 
RACo with TEV protease was included to the standard purification protocol. To check the 
occupancy of the [2Fe2S] cluster the iron content of the protein batch was determined 
(Materials and Methods 5.3). RACo obtained by this purification strategy bound between 47 
and 84 % of iron.  
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Figure 13 shows a SDS-PAGE analysis of RACo samples prepared as described above. 
 
 
 
 
 
Figure 13: SDS-PAGE analysis of RACo samples. The final activator 
fraction after three purification steps was loaded onto a 12% (w/v) SDS 
gel to analyse protein purity. 20 µg of every sample were loaded. Lane 1: 
natively purified RACo; lane 2: RACo purified via affinity 
chromatography; lane 3: Δ100-RACo. Lane M contains a molecular mass 
marker with the indicated sizes in kilodalton. 
2.2. Purification of CoFeSP and CoFeSP Variants 
CoFeSP, ΔN60-CoFeSP, ΔC128-CoFeSP as well as the mutant C25P-CoFeSP were purified 
without chromatography tag applying a four-step purification protocol. The purification 
included two IEC steps, one HIC step followed by SEC chromatography (Materials and 
Methods 4.2.1.3). Approximately 50 – 100 mg of CoFeSP were purified from 20 g cells (wet 
weight) in a standard purification. In the case of the C25P-mutant only 10 mg were obtained. 
The yield of the variants ΔN60-CoFeSP and ΔC128-CoFeSP was 25 and 85 mg, respectively.  
An SDS-PAGE analysis of CoFeSP and the variants ΔN60-CoFeSP, ΔC107-CoFeSP is 
shown in Figure 14. 
 
 
 
Figure 14: SDS-PAGE analysis of CoFeSP samples. The final 
CoFeSP fraction after native purification of CoFeSP (lane 1), ΔC128-
CoFeSP (lane 2) and ΔN60-CoFeSP (lane 3) are shown. About 20 µg 
of protein were loaded onto a 12% (w/v) SDS gel. Lane M contains a 
protein marker with sizes indicated in kilodaltons. 
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3. Biochemical Characterisation of RACo 
3.1. UV-Vis Spectroscopy of RACo 
The primary structure of the orf7 gene product contains a [2Fe-2S] cluster binding motif (C-
X5 -C-X2 -C-Xn –C) and the crystal structure of the protein showed that it contained a plant-
type ferredoxin [2Fe2S] cluster bound to its N-terminus (Figure 13A). This domain shares 
sequence identities with these ferredoxins of 28-30 % and displays the typical β-grasp 
topology with a β-sheet consisting of five β-strands and one α-helix. The [2Fe2S] cluster is 
bound near the surface (Figure 15A).  
 
Figure 15: Structure and UV-Vis spectrum of the plant-type ferredoxin [2Fe2S] cluster bound to the N-
terminus of RACo. (A) The N-terminal domain is shown as grey cartoon. Strands and helices are labelled. 
Cysteine residues coordinating the iron atoms (red spheres) are shown as cyan sticks. Sulfurs are coloured in 
yellow. (B) The spectrum of as-isolated RACo (4 µM) is shown as solid line, the spectrum of reduced RACo as 
dashed line, respectively.  
The UV-Vis spectrum of the (putative) as-isolated activator is characteristic for an oxidised 
cluster of this type (Figure 15B). Maxima at 350, 410 and 460 nm and a shoulder at 550 nm 
are clearly distinguishable (solid line). The cluster was bleached in the presence of 2mM DTT 
within 20 min (dashed line) due to one-electron reduction to its +1 state.   
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3.2. ATPase Activity of RACo 
The orf7 gene product shares a common central fold with members of the ASKHA protein 
family and in the crystal structure a interdomain cleft, where usually nucleotide-binding and 
hydrolysis occur was identified (Figure 12B and C) (47, 48). 
The ATPase activity of RACo was analysed by two different methods (Materials and 
Methods 6). As the ATPase activity of RACo was not influenced by the presence of oxygen, 
most of the experiments were performed under oxic conditions.  
3.2.1. Determination of the Specific ATPase Activity by the MGAM Assay 
For a first determination of the specific ATPase activity of RACo a calorimetric method was 
used. The release of inorganic phosphate was detected via the absorbance of the 
phosphomolybdate-malachite green complex according to a modified protocol (Materials and 
Methods 6.1.1) (109).   
For every sample a control without protein was measured to determine the auto-hydrolysis of 
ATP (Figure 16A, white circles). The absorbance of the sample was corrected by subtracting 
the absorbance of the corresponding control sample. From the change in absorption at 630 nm 
in certain time intervals the phosphate release per minute was calculated. All samples were 
measured in triplicate and average values and the corresponding standard deviations are 
given. 
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Figure 16: Specific ATPase activity of RACo determined by the MGAM assay. (A) Shown are the amounts 
of released phosphate per mg protein of RACo (filled circles), Δ100-RACo (filled triangles) and RACo with an 
N-terminal His-tag (filled squares). All samples were measured at room temperature. (B) Specific activities of 
RACo measured at different temperatures are given with standard deviations. The specific activity of Δ100-
RACo (D100) was measured at room temperature. 
At room temperature RACo (purified natively) displayed a specific activity of 7.49 ± 0.46 mU 
(Figure 16A, filled circles) corresponding to a kcat of 0.51 ± 0.03 min-1. The specific activity 
of Δ100-RACo was determined to be 4.49 ± 0.83 mU (Figure 16A, filled triangles) with a kcat 
of 0.31 ± 0.06 min-1. The specific ATPase activity of RACo with N-terminal His-tag was 
measured at 50°C. The protein showed a low activity of 1.87 ± 0.56 mU in contrast to an 
activity of 43.64 ±1.88 mU determined for RACo without tag at the same temperature (Figure 
16A, squares). A dependency on the temperature was observed: increase in temperature 
resulted in an increase of the specific activity (Figure 16B).  
3.2.2. Coupled ATPase Activity Assay 
A coupled assay (Materials and Methods 6.1.2) was performed for the determination of the 
kinetic parameters of the ATPase activity of RACo. The coupled assay allows for continuous 
measurement and is, compared to the MGAM assay, less time-consuming. 
The ATPase converts ATP to ADP, which is continuously regenerated in the reaction of 
phosphoenolpyruvate to pyruvate catalysed by phosphokinase. Pyruvate reacts to lactate 
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under consumption of NADH mediated by lactate dehydrogenase. The decrease of NADH 
can be followed directly by the decrease in absorption at 340 nm. The consumption of NADH 
and the conversion of ATP by the ATPase are directly coupled (110). 
For the determination of the parameters Km and Vmax of RACo and the active site mutants the 
concentration of ATP in the assay was varied between 0 and 9 mM and rates were plotted 
against the concentration of the nucleotide. Data were fitted applying the Michaelis-Menten 
equation. Every sample was measured at least in triplicate. 
 
Figure 17: Steady-state kinetics of ATP hydrolysis. The steady-state kinetics of wild type (A) and the active 
site mutants of RACo D377A (B), (C) D212A and E404A (D) are shown. 
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Figure 17 displays the steady-state kinetics of ATP hydrolysis. Activity determined with this 
assay was dependent on the presence of Mg2+ and K+ ions in the buffer. The steady state 
kinetic constants of natively purified wild type RACo (panel A) and the active site mutants 
D377A (panel B), D212A (panel C) and E404A (panel D) were determined. The wild type 
shows the highest activity with a kcat of 7.24 ± 0.30 s-1 and Km of 0.39 ± 0.07 mM 
corresponding to a maximum reaction rate (Vmax) of 6.4 ± 0.3 U (mgProtein)-1. As expected, the 
active site mutants show lower catalytic activities than the (natively purified) wild type 
protein. E404A-RACo has an approximately 145-fold lower catalytic activity with a kcat of 
0.048 ± 0.002 s-1 and a slightly increased Km of 0.81 ± 0.11 mM. The aspartate mutants 
D212A-RACo and D377A-RACo exhibit diminished catalytic rates with minor changes in the 
Km values (D212A: kcat = 0.16 ± 0.01 s-1, Km = 0.83 ± 0.10 mM; D377A: kcat = 0.37 ±0.02 s-1 
and Km = 0.52 ± 0.04 mM). 
The discrepancy between the activities obtained by the different assays is conspicuous. The 
assay conditions, however, differ in the composition of the buffer. The buffer first used in the 
coupled assay contains acetates (Table 8, Materials and Methods 6.1.2) that can be a substrate 
of acetate kinase, an enzyme found in almost all anaerobic bacteria and archaea acting in 
important pathways for acetyl-CoA synthesis (118–120). In E. coli acetate kinase is 
abundantly present, even if not grown on acetate (121). Acetate kinase catalyses the reaction 
of acetate to acetyl phosphate under consumption of ATP (122). Thus it is likely that 
impurities in the protein sample influenced the ATPase activity when acetate salts were 
present in the reaction. To check the impact of impurities (acetate kinase and other ATPases) 
on the activity, the assay was performed using the coupled assay in the absence of acetates as 
well as with protein samples of higher purity grade, e.g. RACo purified by a two-step or 
three-step purification protocol including Ni-IMAC (see Materials and Methods 4.2.1.2). 
RACo prepared by this protocol exhibits a decrease in the overall ATPase activity; activities 
are also lower in the presence of chloride salts (Figure 18). 
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Figure 18: Comparison of activities determined in the presence of different ions and with RACo of distinct 
purity grade. Displayed are the specific ATPase activities of RACo determined by the coupled assay in the 
presence of acetate or chloride for natively purified protein (lower purity) (A) and protein purified in a two 
(higher purity) or three-step (highest purity) protocol including IMAC (B). All measurements were carried out at 
least in triplicate. Error bars indicate standard deviations.   
In the presence of acetate, natively purified RACo displays a specific ATPase activity of 6.4 ± 
0.3 U (mgProtein)-1 or 0.620 ± 0.59 U (mgProtein)-1 depending on the purification batch. The 
specific activity in the presence of chlorides of natively purified protein decreased to 174 ± 
22.93 mU (mgProtein)-1 indicating that beside acetate kinases further impurities displaying 
ATPase activity were present (Figure 18A). In contrast, samples of RACo prepared by a two-
step purification including affinity chromatography (Materials and Methods 4.2.1.2) showed 
activities of 20.20 ± 0.72 mU (mgProtein)-1 in the presence of acetate and 10.67 ± 
1.53 mU (mgProtein)-1 in the presence of chlorides. Protein obtained by a three-step purification 
including IMAC (Materials and Methods 4.2.1.2), displayed a minor specific activity of 1.58 
± 0.19 mU (mgProtein)-1 (Figure 18B). Determination of the steady-state kinetic constants 
applying non-linear regression analysis following the Michealis-Menten equation was not 
possible anymore due to low rates in ATP hydrolysis. These values are now in better 
agreement to the activities determined by the malachite green assay. The colorimetric assay 
quantifying the amount of phosphate released by the reaction of the ATPase was also 
performed with acetate in the buffer and increased activities were measured for natively 
purified protein. This demonstrates that the ATPase activity of different RACo batches is 
highly influenced by impurities with mainly (acetate) kinase activity.  
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It has been shown that the ATPase activity of the activator of 2-hydroxyisocaproyl-CoA 
dehydratase from Clostridium difficile increases from 1.5 mU (mgProtein)-1 up to 
50 mU (mgProtein)-1 in the presence of the partner protein dehydratase indicating that 
electron transfer takes place in the protein-protein complex (52, 123). The Fe-protein of 
nitrogenase belongs to a class of nucleotide-switch proteins. It does not exhibit intrinsic 
ATPase activity in the absence of the FeMo-protein, though (18, 124). ATP hydrolysis is only 
observed in the presence of the partner protein indicating that ATP hydrolysis and electron 
transport are efficiently coupled in the nitrogenase complex.  
The influence of the presence of the biological partner, CoFeSP, on the specific ATPase 
activity of RACo was investigated. For the experiment highly pure CoFeSP has been 
mandatory as the determination of the specific ATPase activity is highly dependent on the 
purity of the proteins used in the assay. As shown for RACo, natively purified protein exhibits 
high activities deriving from impurities. Therefore, a distinct strategy was used for the 
purification of CoFeSP (Materials and Methods 4.2.1.4). The specific activity of the CoFeSP 
preparation, determined by the coupled assay, was 0.35 ± 0.21 mU (mgProtein)-1. When 
CoFeSP and RACo were present in the reaction, the activity increased to 38.12 ± 
5.44 mU (mgProtein)-1 (coupled assay) and 46.41 ± 2.84 mU (mgProtein)-1 (MGAM assay) 
(Figure 19). The approximately 25-fold increased activity cannot be explained as simply as 
the sum of the single activities and indicates that RACo´s affinity towards ATP and / or 
hydrolysis rate is higher in the complex. 
 
Figure 19: Comparison of the ATPase activities of CoFeSP, RACo and the RACo:CoFeSP complex. 
Activities were determined by the coupled assay applying 2 µM of protein and 1 mM of ATP. The activity of the 
complex was additionally determined by the MGAM assay with 10 µM of each protein and 5 mM of ATP. 
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3.3. Redox Titration of RACo Combined with EPR 
In cooperation with Dr. Friedhelm Lendzian the redox potential of the cluster bound to RACo 
was determined by titration of the protein with Na-sodium dithionite. The titration was 
performed under anoxic conditions under an atmosphere of nitrogen and samples for EPR 
spectroscopy were taken at every potential step (Materials and Methods 8) and measured as 
described in Materials and Methods 7.2.5. The intensities of the EPR signals of the [2Fe2S] 
cluster bound to RACo at defined potentials were determined (Figure 20A). Relative 
intensities of the EPR signals were plotted against the corresponding potentials and fitted to a 
single-electron Nernstian process (Figure 20B).  
 
Figure 20: Redox titration of RACo. (A) EPR spectra of samples taken at given potentials recorded at 100 K. 
(B) Relative intensities of the EPR signals of the [2Fe2S] cluster were plotted as a function of the equilibrium 
redox potentials. The least-square fit to the Nernst-equation for n=1 with a midpoint potential of -371 mV is 
displayed as a solid line. 
The redox potential determined from the data was –371 mV. The number of electrons in this 
one-electron reduction is 0.47 and is probably an effect of inhomogeneity of the protein 
sample and reflects the actual iron content of the purification batch. 
The midpoint potential of the [2Fe2S] cluster of RACo is similar to the potential of another 
RACE protein (–330 ± 20 mV), namely the activating enzyme of the vanillate- and veratrol-
O-demethylases of Acetobacterium dehalogenans (17) and is comparable to the midpoint 
potential of other plant-type ferredoxins (125, 126). 
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4. Characterisation of the Interactions between RACo and CoFeSP 
4.1. ATP-Dependent Reductive Activation of CoFeSP by RACo 
An ATP dependent activation of the corrinoid containing enzyme by RACE proteins was 
shown for the veratrol-O-demethylase of Acetobacterium dehalogenans (16, 17, 73, 74) and 
for RamA, isolated from Methanosarcina barkeri involved in the activation of the 
monomethylamine corrinoid protein, MtmC (15). Based on these experiments an electron 
transfer assay for CoFeSP and its putative activator was developed (Materials and Methods 
6.2). 
4.1.1. Electron Transfer between the Wildtypes of RACo and CoFeSP 
For the above-mentioned activating enzymes a strong reducing agent is needed for the 
reduction of the FeS clusters. As CoFeSP is reduced by Ti(III)-citrate (94), another reducing 
agent for the reduction of the [2Fe2S] cluster of RACo was required. The addition of 2 mM 
DTT was sufficient to reduce the [2Fe2S] cluster of RACo but neither the cobalamin nor the 
[4Fe4S] cluster of CoFeSP. The reduction of the [2Fe2S] cluster was tracked by the bleaching 
of the bands at 350, 410 and 460 nm (Figure 15B, dashed line and Figure 23A). When the 
reduction was complete after 10 – 20 minutes, electron transfer from [2Fe2S]1+ to Co(II)-
CoFeSP was initiated by the addition of ATP (Figure 21A). The conversion of Co(II) to Co(I) 
was monitored by the decrease of the absorption at 475 nm. A distinct band at 390 nm 
evinced the formation of the Co(I) species (Figure 21B). Important to note is that upon 
electron transfer the [2Fe2S] returned to its +2 state influencing the absorption at 475 nm. The 
electron transfer from RACo to CoFeSP strictly depends on the presence of ATP and 
equimolar concentrations of the activator. No reduction was observed when catalytic amounts 
of RACo were applied in the assay as the slow reduction of the [2Fe2S] cluster by DTT is the 
limiting step in this single turnover experiment. 
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Figure 21: ATP-dependent electron transfer from RACo to CoFeSP. (A) The changes in absorption are 
induced by ATP addition as can be seen from the time-dependent change in extinction at 390 nm (white circles) 
and 475 nm (black circles). (B) The transfer of the electron from the reduced [2Fe2S] cluster of RACo to Co(II)-
CoFeSP can be followed by UV-vis-spectroscopy and is indicated by the decrease in absorption at 475 nm 
(Co(II)-signal) and the increase of the signal at 390 nm (Co(I)-peak).  
The electron transfer rate constants were determined by single-exponential fits. The 
catalytical rate of a typical assay reaction (initiating the transfer of the electron by addition of 
1 mM ATP) was 1.27 ± 0.23 min-1 corresponding to a specific electron transfer activity of 
RACo of 18.62 ± 3.44 mU (mgProtein)-1. When the reaction was performed with 0.5 mM 
ATP, the catalytical rate decreased to 0.51 ± 0.09 min-1 resulting in a specific activity of 7.47 
± 1.28  mU (mgProtein)-1. All measurements were carried out at least in triplicate. 
Figure 22 shows exemplary ET experiments with 1 and 0.5 mM ATP added. Preliminary 
experiments had already demonstrated the dependency of the electron transfer rate on the 
ATP concentration (Appendix Figure 52). 
 54 
  RESULTS AND DISCUSSION 
 
Figure 22: Dependency of the ET on the ATP concentration. Exemplary changes in the extinction at 390 nm 
upon reduction of CoFeSP by RACo initiated by 1 mM (white circles) and 0.5 mM (white triangles) ATP are 
shown. Experimental data points were fit to single-exponential equation to calculate the corresponding rate 
constants. Fitting curves are presented in blue (1 mM ATP) and green (0.5 mM ATP). The catalytice rate of ET 
initiated by the addition of 1 mM ATP was calculated to be 0.932 min-1. The same experiment with 0.5 mM ATP 
resulted in a catalytic rate of 0.494 min-1.   
Usually, RACo activated approximately 70 % of CoFeSP present in the reaction. The yield of 
Co(I)-CoFeSP was dependent on the cobalamin content of the different purification batches of 
CoFeSP. At constant concentrations of Co(II)-CoFeSP, increased concentrations of RACo did 
not result in a significant increase of the Co(I)-CoFeSP signal. 
The reductive activation activity of RACo (0.3 nkat mg-1 in the presence of 1 mM of ATP) is 
comparable to the corrinoid reduction activities of other RACE proteins (74). A reduction 
activity of 0.3 nkat mg-1 was reported for the corrinoid-dependent methylamine 
methyltransferases of M. barkeri (15) and Dhaf_2573 of D. hafniense DCB-2 activated the 
corrinoid protein Dhaf_4611 with 0.5 nkat mg-1 (73). 
As the catalytic rates of the ATPase reaction (in the absence of acetate) and of the electron 
transfer are in the same range, both processes are presumptively coupled.  
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4.1.2. Electron Transfer Assay Performed with Mutants of RACo and CoFeSP 
The electron transfer assay was also performed with the active site mutants D212A-, D377A- 
and E404A-RACo to check whether the transfer of the electron is dependent on ATP binding 
or ATP hydrolysis. Figure 23 shows exemplarily the spectra of the reduction of the mutant 
D377A-RACo (Figure 23A) and ATP-induced electron transfer. No ATP-induced reduction 
of CoFeSP by the active site mutant(s) D121A, D377A and E404A was detectable. However, 
re-oxidation of the [2Fe2S] cluster was observed (Figure 23B) upon ATP addition. 
Dithiothreitol seems to be the electron acceptor as implied by the change in absorption at 
315 nm. The excess of DTT in the reaction resulted in a slow re-reduction of the cluster (not 
shown). 
 
Figure 23: Electron transfer assay performed with the active site mutant D377A. (A) The reduction of 
10 µM of the RACo mutant D377A in the presence of 10 µM CoFeSP and 2 mM DTT was followed by UV-vis 
spectroscopy. The decrease in absorption at 350, 410 and 460 nm and increase at 315 nm display the electron 
transfer from DTT to the [2Fe2S] cluster. (B) Addition of 1 mM of ATP caused the re-oxidation of the reduced 
cluster. Electron transfer from the [2Fe2S] cluster of RACo to Co(II)-CoFeSP was not detected. 
The ATPase activity measurements did not reveal whether the mutation of single residues of 
the active site had changed the binding and / or hydrolysis behaviour of the protein (Results 
and Discussion 3.2.2) and it is hard to conclude if the activities of wildtype and mutants really 
differ. The modification of the nucleotide-binding site definitely influences the electron 
transfer ability of RACo (Figure 23) indicating that mutagenesis of specific residues within 
the nucleotide-binding site bias the function as electron transferase.    
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The ET assay was performed with the CoFeSP variants ΔN60-CoFeSP and ΔC128-CoFeSP as 
well as with apo-CoFeSP (not B12-reconstituted). No electron transfer between RACo and 
CoFeSP lacking its N-terminal [4Fe4S]-binding domain (ΔN60-CoFeSP) was observed. 
Furthermore, in the presence of apo-CoFeSP and ΔC128-CoFeSP, spectral changes indicating 
that the electron was transferred to the [4Fe4S] cluster of CoFeSP (in the absence of the 
corrinoid) were not detected neither. In all experiments reoxidation of the [2Fe2S] cluster of 
RACo was monitored.  
The mutant C25P-CoFeSP, presumably binding a [3Fe4S] cluster, was prepared (Materials 
and Methods 3.3.2) to investigate the role of the FeS cluster in the conduit of the electron 
from the reduced [2Fe2S] of RACo to the cobalamin bound to CoFeSP. The alteration of the 
cluster theoretically increases the redox potential and should abort the electron flow if it was 
part of the conduit (99). The assay was performed with C25P-CoFeSP as described for 
wildtype CoFeSP. Reduction of the cobalamin was observed with a catalytical rate of 1.09 ± 
0.12 min-1 (Figure 24). As the catalytical rates are almost the same and the yield of Co(I) in 
both cases was approximately 65 %, it is rather implausible that the [FeS] cluster bound to 
CoFeSP is part of the conduit of electrons from the [2Fe2S] cluster to the cobalamin.  
 
Figure 24: Comparison of electron transfer mediated by RACo to wild type CoFeSP and the C25P mutant 
of CoFeSP. The changes in extinction at 390 nm of wildtype CoFeSP (circles) and of the C25P mutant 
(triangles) upon reduction by RACo are shown. The fitting curves are shown in blue (wildtype) and green 
(mutant). 
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All results demonstrate that RACo is able to transfer one electron from its [2Fe2S] cluster to 
the cobalamin of Co(II)-CoFeSP in an ATP-dependent process (Figure 21) The data of the 
C25P mutant do not indicate for a role of the [4Fe4S] cluster of CoFeSP during the reduction 
of the cobalamin as suggested by Menon (99, 100). 
The results described in this chapter clearly establish the orf7 gene product as the reductive 
activator of CoFeSP. The scheme of the reductive acetyl-CoA pathway of C. 
hydrogenoformans can therefore be extended by the “reductive activation” mediated by 
RACo (Figure 25).  
 
Figure 25: Reductive acetyl-CoA pathway of C. hydrogenoformans including the reductive activation of 
CoFeSP by RACo. In case of incidental oxidation of Co(I)-CoFeSP to Co(II)-CoFeSP one electron is 
transferred by RACo in an ATP-consuming reaction. Reactivated Co(I)-CoFeSP can then return to the catalytic 
cycle and is ready to accept the methyl group from methyltransferase. 
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4.2. Complex Formation between CoFeSP and Its Reductive Activator RACo 
4.2.1. Redox State-Dependent Complex Formation  
Analytical size exclusion chromatography was used for the first investigation of the 
interactions of RACo and CoFeSP (Materials and Methods 5.4) 
The single proteins display clearly distinguishable peaks with defined elution volumes on a 
SuperdexTM 200 gel filtration column. The oligomeric state of RACo in solution was 
determined to be a homodimer with a molecular mass of 158 kDa corresponding to an elution 
volume of 68.3 mL. CoFeSP is a heterodimer composed of the two subunits CfsA and CfsB. 
With an elution volume of 77.5 mL the molecular mass was calculated to be 78 kDa (Figure 
26A). An additional peak was observed, when both proteins were incubated in equimolar 
amounts in buffer containing 2 mM DTT and loaded onto the column. The elution volume of 
60.3 mL corresponds to a molecular mass of 280 kDa (Figure 26B, solid line). The peak 
fractions were collected and analysed by SDS-PAGE. The fractions of the first peak clearly 
display three bands corresponding to RACo (68 kDa as monomer) and CoFeSP (with 48 kDa 
for CfsA and 34 kDa for CfsB) (Figure 26E). Densitometric analysis of the SDS gel indicates 
that one RACo molecule forms a complex with one CoFeSP molecule. Assuming a 2:2:2 
stoichiometry of CfsA, CfsB and RACo in solution, the molecular size of the complex 
determined by gel filtration, is in perfect agreement with the calculated theoretical molecular 
mass of 300 kDa. This indicates that RACo forms a stable complex with the inactive Co(II)-
CoFeSP – but leaves the question if the activator distinguishes between the inactive state and 
the two active states of CoFeSP. To test the affinity of RACo towards the different redox 
states of CoFeSP, RACo was incubated with reduced Co(I)-CoFeSP (prepared by incubation 
for 15 min with 1 mM DT) and run on a gel filtration column in the presence of 1 mM DT. 
Peaks for the single proteins, but no complex peak, were recorded (Figure 26B, dashed line). 
When methylated CH3-Co(III)-CoFeSP, the second active form of CoFeSP was incubated 
with RACo, a small complex fraction was obtained (Figure 26B, dotted line), which possibly 
derived from photolysis of the light sensitive bond between the CH3 group and the cobalt.  
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Figure 26: Complex formation between RACo and CoFeSP. (A) Individual elution profiles of RACo (29 µM) 
and CoFeSP (11 µM). The RACo peak corresponds to a homodimer of 158 kDa. The heterodimer CoFeSP has 
an apparent mass of 86 kDa. (B) Complex formation in dependence of the redox state of CoFeSP. RACo was 
mixed with the three possible redox states of CoFeSP: Co(II)-CoFeSP (solid line), Co(I)-CoFeSP (dashed line) 
and CH3-Co(III)-CoFeSP (dotted line). (C) Elution profile of Δ100-RACo mixed with Co(II)-CoFeSP. Due to 
the smaller molecular size of Δ100-RACo the complex peak is shifted to 62.4 mL corresponding to a molecular 
mass of 241 kDa. (D) Comparison of complex formation between wild type Co(II)-CoFeSP and Δ60- Co(II)-
variant with RACo. No complex peak is observed when Δ60-CoFeSP was incubated with RACo. (E) SDS-
PAGE analysis of the main peak fractions of RACo incubated with Co(II)-CoFesP (B, solid line). The first lane 
shows the molecular mass marker with the molecular masses given in kilodaltons. Peak fractions and 
corresponding protein bands are labelled. 
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The [2Fe2S] cluster of RACo is the electron donor in the reactivation of CoFeSP. To test 
whether it is also important for the formation of the complex the entire N-terminal [2Fe2S] 
cluster domain and a part of the long linker were removed (Figure 13A) to obtain Δ100-RACo 
(Materials and Methods 3.2.1). When Co(II)-CoFeSP was incubated with Δ100-RACo 
(elution volume 72.5, 113 kDa) a peak at an elution volume of 62.4 mL corresponding to the 
Δ100-RACo:CoFeSP complex with a molecular mass of 241 kDa was observed (Figure 26C).  
Like RACo, CoFeSP harbours its [4Fe4S] cluster at its N-terminus in a flexible domain 
(Figure 10). The deletion variant ΔN60-CoFeSP, lacking the whole [4Fe4S] cluster-binding 
domain, was tested for complex formation with RACo, but no complex was formed (Figure 
26D). In contrast to the [2Fe2S] domain of RACo the [4Fe4S] domain of CoFeSP seems to 
contribute to the stabilisation of the protein-protein complex. 
Further the influence of nucleotides upon complex formation was tested. The proteins were 
incubated in buffer containing either 5 mM ATP or ADP and loaded onto a Superdex S 150 ∕ 
5 analytical column (dimension 5 × 150 mm, GE Healthcare) equilibrated in buffer containing 
5 mM of the nucleotide. The presence of nucleotide did not affect the complex formation 
(Figure 27). In a second approach the necessity for DTT was tested and a sample without 
DTT was loaded onto the column. However, complex formation was observed under all 
conditions (Figure 27). 
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Figure 27: Complex formation in the presence of nucleotide. (A) Elution profiles of the individual proteins in 
the presence of 2 mM DTT. Experiments were performed on a Superdex S 150/5 column (dimension 5 x 
150 mm). RACo were eluted at 1.61 mL (dashed line) and CoFeSP at 1.86 mL (solid line), respectively. (B) 
Elution profile dependence on the redox state of activator and the presence of ADP or ATP. In the absence of 
DTT in the running buffer, the oxidised state of the activator formed a complex with Co(II)-CoFeSP (dashed 
line, EV 1.46 mL). Irrespective of the presence of ADP (solid line, EV 2.64 mL) or ATP (dotted line, EV 2.65 
mL), the complex specific peak was observed. 
From the analytical size exclusion experiments one can conclude that the redox state of the 
activator has no impact on complex formation as the absence or presence of DTT did not have 
any effect on the formation of the additional complex peak. The presence or absence of 
nucleotide does not affect the interactions of the two proteins. The N-terminal domain of 
CoFeSP seems to play a role in the stabilisation of the complex as no complex formation was 
observed between Δ60-CoFeSP and RACo. In contrast, complex formation between Δ100-
RACo and CoFeSP was detected irrespectively of the absence of the N-terminal of RACo. 
Complex formation observed in these experiments, is not affected by the presence of 
nucleotides and marks a crucial difference to the complexes found in nitrogenase or 
dehydratase. In nitrogenase the nucleotide-binding acts as a switch for complex association 
and dissociation (21, 35) and conformational changes of the activator induced by nucleotide-
binding enhance complex formation in dehydratases (44, 50–52). 
Complex formation depends strictly on the redox state of the cobalamin cofactor bound to 
CoFeSP. The high substrate affinity of RACo towards inactive Co(II)-CoFeSP combined with 
the low affinity for the product Co(I)-CoFeSP has not been observed in any other ATP-
dependent activation system. Redox-state dependent complex formation seems to be a 
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feasible strategy to assure uni-directional electron flow from the [2Fe2S] cluster bound to 
RACo and the cobalamin cofactor of CoFeSP. 
4.2.2. Determination of the Dissociation Constant of the RACo:CoFeSP Complex  
Redox-dependent complex formation between RACo and CoFeSP was solely qualitatively 
determined by analytical size exclusion chromatography (previous paragraph), while the 
determination of the binding / dissociation constant of the complex was performed by protein-
protein isothermal titration calorimetry with different RACo variants. Co(II)-CoFeSP was 
titrated inside a glove box (under an atmosphere of nitrogen with [O2]<0.5 ppm) either with 
wild type RACo or Δ100-RACo. Protein solutions were prepared and experiments were 
performed as described in Materials and Methods 5.5. 
Figure 28 shows the raw measured heat changes as a function of time in the upper panel. The 
corresponding normalised measured heats of injections are illustrated in the panels below. 
The parameters were calculated using supplier’s software assuming a one-site binding model. 
The dissociation constants KD determined for the RACo:CoFeSP complex and the Δ100-
RACo:CoFeSP complex are comparable. For the “complete” complex a KD of 18.1 ± 2.8 nM 
was obtained (Figure 28A). The KD of the complex lacking the [2Fe2S] cluster domain of 
RACo was calculated to be 6.7 ± 0.8 nM (Figure 28B). The different complex samples exhibit 
very similar dissociation constants. As analytical gel filtration already has indicated, the N-
terminal domain of RACo does not contribute to the stabilisation of the complex formed 
between the activator and CoFeSP. 
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Figure 28: ITC data of the titration of RACo (A) and ∆100-RACo (B) to CoFeSP. Shown are the binding 
isotherms with exothermic heat change (upper) and the fit of the integrated enthalpic changes to a one-site 
binding model. Dissociation constants KD are 18.1 ± 2.8 nM for RACo and 6.7 ± 0.8 nM for ∆100-RACo. 
Protein concentrations used in the titrations were 100 µM for RACo and ∆100-RACo and 10 µM for Co(II)-
CoFeSP. 
The stoichiometries of all titrations are far below 1 indicating that not all molecules form a 
complex. Stoichiometry depends on the protein concentration. The low stoichiometries most 
probably reflect the concentration of “active” species in the titration.  
ITC was performed to quantify the affinity of RACo and Co(II)-CoFeSP to each other. The 
dissociation constants in a low nanomolar range describe strong interactions between the two 
partners and confirm the formation of a stable complex between Co(II)-CoFeSP and its 
activator RACo. Interprotein electron transfer (Results and Discussion 4.1) presumably occurs 
within the RACo:CoFeSP complex. The low catalytic rates of the activation of CoFeSP by 
RACo indicate that catalytic amounts of RACo slow down the electron transfer. 
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4.3. Influence of Complex Formation on the Cofactors 
The RACo:CoFeSP complex contains three metallo cofactors that are supposed to be 
sensitive to changes in their direct environment upon complex formation. Resonance Raman 
(RR) and electro paramagnetic resonance (EPR) spectroscopy were conducted to investigate 
the environmental changes due to interactions between RACo and CoFeSP. These 
spectroscopic experiments were carried out in the laboratory of Prof. Dr. Peter Hildebrandt 
(Institut für Chemie, Technische Universität Berlin) and the results from this cooperation 
(Results and Discussion 4.3.1 and 4.3.2) have been published (111). 
4.3.1. Resonance Raman Spectroscopy 
Resonance Raman spectroscopy was used to investigate specific structural changes in the 
periphery of the cofactors of RACo ([2Fe2S] cluster) and Co(II)-CoFeSP (corrinoid and 
[4Fe4S] cluster) deriving from interactions of the two proteins upon complex formation.   
For the RR measurements performed by Wiebke Meister (Institut für Chemie, Technische 
Universität Berlin) samples of RACo, Co(II)-CoFeSP, RACo:Co(II)-CoFeSP complex, Δ100-
RACo, Δ100-RACo:Co(II)-CoFeSP complex, Co(I)-CoFeSP, ΔN60-Co(II)-CoFeSP and 
ΔC107-Co(II)-CoFeSP with and without RACo were prepared as described in Materials and 
Methods 7.2.1. The protein variants, each lacking one of the cofactor carrying domains, were 
used to facilitate the assignment of the signals to the different cofactors. 
The spectra shown in Figure 29 illustrate the frequency range of the C=C stretching modes of 
the corrin macrocycle of CoFeSP since the spectrum of RACo does not contain any peak in 
the range between 1450 and 1650 cm-1 (Figure 29A). Three bands in the region between 1450 
and 1650 cm-1 can be assigned to cobalamin (127–130). Oxidised Co(II)-CoFeSP gives 
signals  at 1604, 1543 and 1498 cm-1 (Figure 29C). The C=C stretching modes depend on the 
oxidation state of the cobalt ion and a small downshift of 4 – 5 cm-1 in the spectrum of 
reduced Co(I)-CoFeSP (Figure 29B) could be observed. Interactions with RACo do indeed 
influence the corrin macrocycle as the spectrum of the complex sample (Figure 29D) 
illustrates. Complex formation results in an upshift from 1604 to 1607 cm-1 and from 1543 to 
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1545 cm-1. A 2 cm-1 downshift is apparent for the band at 1498 cm-1. Neither the [2Fe2S] 
cluster nor the [4Fe4S] cluster display RR bands in this range as the spectra of the complex 
lacking the [2Fe2S] cluster with the same signal patterns demonstrate (Figure 29E). Identical 
shifts of the cobalamin peaks indicate that the complex formed between Δ100-RACo and 
CoFeSP has the same electronic structure of the corrin macrocycle as the complex between 
RACo and CoFeSP. No peaks are found in the spectrum of CoFeSP lacking the C-terminal 
cobalamin-binding domain but containing the N-terminal bound [4Fe4S] cluster (Figure 29F). 
 
Figure 29: Resonance Raman spectra in the frequency range of 1450 – 1650 cm-1. RR spectra obtained with 
413 nm excitation of RACo. (A), Co(I)-CoFeSP (B), Co(II)-CoFeSP (C), RACo:Co(II)-CoFeSP (D), Δ100-
RACo:Co(II)-CoFeSP (E) and ΔC106-CoFeSP (F). The frequency range of the C=C stretching modes of the 
corrin macrocycle of CoFeSP is displayed. Shifts are indicated by dashed lines and wave numbers of the peaks 
characteristic for the corrinoid are given. 
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The frequency range between 280 and 400 cm-1 is assigned solely to the [FeS] clusters 
(Figure 30) since the spectra of the deletion mutants Δ100-RACo and Δ60-CoFeSP do not 
display any features in this region (Figure 30A and E). Five peaks at 288, 320, 327, 344 and 
390 cm-1, respectively, characterise the spectrum of RACo binding the [2Fe2S] cluster 
(Figure 30B). The spectrum of the [4Fe4S] cluster of CoFeSP shows three peaks at 335, 346 
and 359 cm-1 (Figure 30D). The complex sample displays a mixture of both (Figure 30C). The 
spectrum of free Co(II)-CoFeSP (Figure 30D) and free RACo (Figure 30B) were subtracted 
from the complex spectrum and an effect on the [FeS] clusters due to the interactions between 
the two proteins can be excluded as the resulting spectra display the spectra of the free 
proteins (Figure 31). 
 
Figure 30: RR spectra of the [FeS] cluster frequency range. Spectra of Δ100-RACo (A), RACo (B), the 
RACo:Co(II)-CoFeSP complex (C), Co(II)-CoFeSP (D) and Δ60-Co(II)-CoFeSP, obtained with 413 nm 
excitation. The frequency range of the fundamentals of the [FeS] centres is shown. Asterisks mark peaks 
deriving from non-lasing emission lines of the Kr+ ion laser. 
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Figure 31: Difference spectra. (A) Comparison of the difference spectrum “complex – RACo” (red) and 
Co(II)-CoFeSP (black). (B) Spectrum of RACo (black) and the difference spectrum “complex – Co(II)-CoFeSP” 
(red). (C) Complex spectrum (black) and sum spectrum “RACo + Co(II)-CoFeSP” (red). All spectra were 
obtained with 413 nm excitation and display the range of the [FeS] cluster. Asterisks label peaks deriving from 
non-lasing emission lines of the Kr+-ion laser. 
Resonance Raman spectroscopy revealed perturbation of the (electronic) structure of the 
corrin macrocycle upon complex formation between CoFeSP and RACo. As the absence of 
the [2Fe2S] cluster binding domain in the Δ100-RACo:CoFeSP complex resulted in the same 
upshifts compared to the spectrum of free CoFeSP, it is clear that the alteration in the 
structure of the corrin ring is not a consequence of interactions with this domain.  
The results obtained in these experiments demonstrate that the interactions between RACo 
and CoFeSP bias the cobalamin cofactor but none of the [FeS] clusters. 
 68 
  RESULTS AND DISCUSSION 
4.3.2. EPR Spectroscopy of CoFeSP and the RACo:CoFeSP Complex 
In addition to RR spectroscopy, EPR spectroscopy was performed to visualize the alterations 
on the cobalamin cofactor observed in the RACo:CoFeSP complex. Samples were prepared as 
described in Materials and Methods 7.2.4 and EPR spectra were measured (Materials and 
Methods 7.2.5) by Dr. Friedhelm Lendzian (Institut für Chemie, Technische Universität 
Berlin). The obtained EPR spectra have been published (111).  
Cobalamin in its Co(II) state is EPR active and the EPR spectrum of Co(II)-CoFeSP shows a 
broad pattern of eight lines resulting from hyperfine interactions of the unpaired electron and 
the cobalt nucleus, in the region of 2,500 to 3,800 G (Figure 32a). The spectrum is typical for 
Co(II)-cobalamin in its base-off conformation found in corrinoid iron/sulfur proteins (67, 68, 
130).  
The spectrum was compared with a spectrum of a sample containing Co(II)-CoFeSP and 
RACo in the presence of DTT (Figure 32b). The cobalt signal of the complex sample is 
sharper and better resolved on the low-field than is the one of CoFeSP alone. The dominant 
signal at 3,250 to 3,500 G in the complex spectrum is assigned to the EPR active [2Fe2S]1+ 
cluster bound to RACo. 
 
Figure 32: EPR spectra of Co(II)-CoFeSP (a) and the RACo:Co(II)-CoFeSP complex (b). The broad low-
amplitude signals between 2,500 and 3,800 G are assigned to the corrinoid cofactor. In the complex sample these 
signals are sharper and better resolved indicating well-defined ligand-Co interactions. The dominant signal in the 
complex spectrum (b) derives from the reduced [2Fe2S] cluster of RACo. Corresponding signals of corrinoid of 
free Co(II)-CoFeSP and complex are labelled.  
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The better resolution of the Co2+ signal reflects a change in the cobalamin coordination and 
supports the results obtained by resonance Raman spectroscopy. The weak, loose interaction 
with the water ligand observed in the crystal structure of CoFeSP (Figure 10) (94) seems to be 
lost and  replaced by a strong interaction with an axial ligand, possibly allocated by RACo.  
4.3.3. Redox Titration of CoFeSP and the RACo:CoFeSP Complex Combined with EPR  
The electron transfer from the [2Fe2S] cluster of RACo to the cobalamin of CoFeSP is 
energetically an uphill process against an electrochemical gradient. Midpoint reduction 
potentials of the cofactors of CoFeSP of M. thermoacetica were determined to be –504 mM 
for the cobalamin and –523 mM for the [4Fe4S] cluster, respectively (68). The midpoint 
potential of the [2Fe2S] cluster of RACo was assessed to be –371 mV (Results and 
Discussion 3.3) and is in a line with the activating enzyme of veratrol-O-demethylase (17). 
The midpoint reduction potential of the corrinoid protein of veratrol-O-demethylase increases 
from below –450 mV to –320 mV in the presence of the activating enzyme enabling the 
transfer of one electron from the [2Fe2S] cluster to the corrinoid (16, 17). 
To gain insights how complex formation influences the redox behaviour of the cofactors, in 
addition to the redox titration of RACo (Results and Discussion 3.3), titrations of CoFeSP and 
the RACo:CoFeSP complex were performed in cooperation with Dr. Friedhelm Lendzian 
(Institut für Chemie, Technische Universität Berlin).  
Samples were prepared and treated as described in Materials and Methods 8. EPR spectra 
were recorded at 100 K to detect signals of the (reduced) [2Fe2S] cluster and (oxidised) 
cobalamin or at 10 K for the detection of the (reduced) [4Fe4S] cluster of CoFeSP. All spectra 
were corrected by subtracting reference buffer spectra. The EPR intensities were normalised 
to one for all EPR active species, e.g. the signal of Co(II) at the most positive potential was 
assumed to represent 100 % of the cobalamin present in the sample. The [FeS] clusters are 
EPR silent in the 2+ state and the intensities at the lowest potentials were used for 
normalisation. The corrected intensities were plotted against the potentials of sampling and 
curves were fitted applying the Nernst-equation of a single-electron process. 
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The results of the redox titration of CoFeSP are illustrated in Figure 33. The single spectra of 
the different potential steps at 100 K (A), at 10 K (B) and the corresponding Nernst plots (C) 
are shown.  
 
Figure 33: Redox titration combined with EPR of CoFeSP. (A) EPR spectra of CoFeSP recorded at 100 K. 
The signal of the mediators is labelled with an asterisk. (B) Spectra of the [4Fe4S] cluster taken at 10 K. The 
signal assigned to the cluster is marked with a black arrow; the mediator signal is labelled with an asterisk. (C) 
Nernst plots of the cofactors of CoFeSP. The Nernst fit of the cobalamin (black) results in a midpoint potential 
of –447 mV (n = 0.30). For the [4Fe4S] cluster (blue) the midpoint reduction potential was calculated to be –
549 mV (n = 1, fixed).  
The midpoint potential of the Co(I)/Co(II) couple was calculated to be –447 mV. According 
to the result of the Nernst-fit only 30 % (n=0.30) of the cobalamin was reduced. The plot of 
the [4Fe4S] cluster faces the problem that a strong intensity was only obtained at the lowest 
potential when already 0.9 spins / protein were reached. For the fitting the value of n had to be 
set to one. The midpoint potential from the fit was calculated to be –549 mV.   
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The midpoint potentials determined for CoFeSP of C. hydrogenoformans are comparable to 
those reported for CoFeSP of M. thermoacetica and M. thermophila (67, 68). The negative 
potential of the [4Fe4S] cluster even emphasises more the mysterious role of this metal 
centre.   
A sample of both proteins in equimolar concentrations was titrated with DT and EPR spectra 
were recorded as for the single proteins (Materials and Methods 8). The spectra recorded at 
100 K (A) and 10 K (B) and the corresponding Nernst plots (C) are presented in Figure 34. 
 
Figure 34: Redox titration combined with EPR of the RACo:CoFeSP complex sample. (A) Spectra of the 
complex sample measured at 100 K. The Co(II)-corrin signals are well conserved over the whole potential range. 
The signal of the reduced [2Fe2S] cluster of RACo arises at a potential of –269 mV. (B) EPR spectra recorded at 
10 K. The signal of the reduced [4Fe4S] cluster (black arrows) is significant only at the most negative potential. 
The signal of the [2Fe2S] cluster is less strong at this temperature. The strong signal in the low potential range 
arises from the mediator mix and is labelled with an asterisk. (C) Nernst plots of the cofactors present in the 
complex. The potentials are plotted against the intensities and the curves were fitted according to the Nernst 
equation assuming for all cofactors a one-electron reaction. For the [2Fe2S] cluster of RACo (red) a midpoint 
potential of –337 mV (n = 0.64) was calculated. The [4Fe4S] cluster of CoFeSP (blue) has a midpoint potential 
of –560 mV (n = 1, fixed). The cobalamin of CoFeSP (black) is not reduced and the Co(II) state is observed over 
the whole potential range. 
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As in the free protein the redox potential of the FeS cluster of CoFeSP is rather negative (–
560 mV) and a strong signal was only observed at the lowest potential. No dramatic changes 
in the redox behaviour of RACo were observed as the midpoint potential of the [2Fe2S] 
cluster in the complex (–337 mV) and the midpoint potential of uncomplexed RACo (–
371 mV, Results and Discussion 3.3) are similar. The variation remained within the 
experimental error limits. Complex formation affected the cobalamin cofactor exclusively. In 
the complex sample, hardly any transition from the EPR active to the EPR silent Co(I) species 
was observed.  
The Co(II) state was highly stabilised and the cofactor seems to be specially protected by the 
interactions with RACo. Even at the lowest potential reached during titration 90 % of the 
cobalamin remained oxidised. This result is oppositional to RACo´s original task as reductive 
activator. The reduction of Co(II)-CoFeSP to the active Co(I)-CoFeSP should be facilitated 
by the interaction with RACo. 
As the midpoint reduction potential of the [2Fe2S] was not affected by complex formation the 
strategy for the electron transfer seems to be different to other ATP dependent activators 
where the protein-protein interactions mainly bias the electron donating centre adapting a 
potential as negative as the one of the acceptor site. Complex formation between the Fe-
protein and the MoFe-protein of nitrogenase lowers the midpoint potential of the reductase by 
about –200 mV via the desolvation of its negatively charged [4Fe–4S] cluster (131, 132) as 
also suggested for radical dependent β,α-dehydratases (133–135). RACE proteins seem to 
modulate the midpoint potential of the corrinoid but in contrast to the activating enzyme of 
the veratrol-O-demetylase (16, 17), RACo decreases the midpoint potential of the cobalamin.  
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5. Crystal Structure of the RACo:Co(II)-CoFeSP Complex at 2.5 Å Resolution 
For the crystallisation of the protein-protein complex fractions from several gel filtration 
experiments (Results and Discussion 4.2) were pooled and concentrated (Materials and 
Methods 9.1). Commercially available screens were used for the initial screening. Over a 
period of 18 months crystals (Figure 35) grew in 27 conditions, mainly of the Index and PEG-
Ion screen (Hampton Research). All conditions contained PEG3350 with pH ranging from 5.5 
to 8.5. Crystals of all conditions were tested for diffraction. Generally, crystals diffracted to 
7 Å or lower except for one, which diffracted to 3.3 Å and could be indexed. Another crystal 
from a 13 months old plate even diffracted to 2.5 Å and data were processed with XDS (113). 
The crystal belonged to space group P1 with cell parameters a = 67.13, b = 128.18 and c = 
163.37, α = 77.61, β = 82.25 and γ = 88.76. Calculation of the Matthew’s coefficient 
suggested four molecules per asymmetric unit considering a molecular size of 150 kDa per 
complex molecule. The structure was solved by molecular replacement using the known 
structures of the complex components, RACo (PDB 3ZYY) (102) and CoFeSP (PDB 2YCL) 
(94) as replacement models. Statistics of data collection and refinement are summarised in 
Appendix Table 22. 
 
Figure 35: Crystals of the RACo:CoFeSP complex. Shown are two exemplary crystallisation drops. Crystals 
appeared after several months. 
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5.1. The Overall Structure of the RACo:CoFeSP Complex 
In the asymmetric unit two copies of the RACo:CoFeSP complex were found. The 
physiological complex is composed of two RACo and CoFeSP molecules (Figure 26E and 
Figure 36) in perfect agreement with the 2:2:2 stoichiometry found in solution (see Results 
and Discussion 4.2.1). 
The RACo homodimer is flanked at each side by a CoFeSP heterodimer which consists of 
two (β/α)8 barrel domains, the small subunit CfsB and the middle domain of CfsA. The N and 
C-terminal domains of the large subunit CfsA carry the cofactors: the N-terminal bound 
[4Fe4S] cluster and the cobalamin cofactor at the C-terminus (Figure 10). All domains of 
CoFeSP are visible in the complex structure (Figure 36), even the N-terminal domain, which 
was not resolved in a previously reported CoFeSP structure (89). RACo is composed of three 
domains (N-terminal [2Fe2S] binding domain, middle domain and C-terminal ASKHA 
domain). The N-terminal [FeS] cluster-binding domain of RACo is bound to the middle 
domain by a long linker (Figure 13A). In the complex structure this domain is not resolved in 
any of the four RACo molecules found in the asymmetric unit. The dissociation constant of 
6.7 ± 0.8 nM of the Δ100-RACo:CoFeSP complex determined by ITC (Results and 
Discussion 4.2.2, Figure 28B) and the observed complex peak from gel filtration experiments 
(Results and Discussion 4.2.1, Figure 26C) showed that this domain does not contribute to the 
stabilisation of the complex. Most likely, there are no interactions with other domains of the 
protein-protein complex stabilising it. In the structure of free RACo a high flexibility was 
observed for the N-terminal domain and could only be modelled in one of the two monomers 
(Figure 13A). This flexibility seems to be retained in the complex.  
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Figure 36: Overall crystal structure of the RACo:CoFeSP complex. The structure is represented as cartoon 
with the RACo homodimer at its core (dark and light pink). The large subunit of CoFeSP, CfsA, is coloured in 
dark and light blue. The small subunit, CfsB, is shown in yellow. The [4Fe4S] cluster of CoFeSP is depicted as 
spheres and the cobalamin is shown as cyan sticks. Additionally, the surface of the complex is shown.   
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Interactions between RACo and the N-terminal domain of CfsA as well as with the small 
subunit CfsB are found at the complex interfaces (Figure 37A and B). H-bonds and 
hydrophobic interactions are formed between a helix of CfsB and residues of the ASKHA 
domain of RACo (Figure 37C). The same helix is involved in the binding of MeTr to CoFeSP 
(98). 
 
Figure 37: Interaction interfaces of the RACo:CoFeSP complex. (A) Interacting residues (shown as stick 
model) of the ASKHA domain of one RACo monomer (dark pink) with the N-terminal [4Fe4S] cluster-binding 
domain of CfsA (blue). (B) Residues of the middle domain of the second RACo monomer (light pink) 
interacting with the N-terminal domain of CfsA (blue). Iron and sulfur atoms of the cluster are presented as 
orange and yellow spheres, respectively. (C) The interaction interface of the small CoFeSP subunit (yellow) with 
the ASKHA domain of RACo (dark pink). Putative H-bonds are shown as dashed lines. 
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5.2. Domain Movements within CoFeSP  
The relative positions of the two (β/α)8 barrel domains of CoFeSP are not affected by 
complex formation. However, the C-and N-terminal domains bound to the large subunit CfsA 
via flexible linkers (Figure 10) are displaced in the complex structure. The superimposition of 
uncomplexed CoFeSP (PDB 2YCL) (94) to the complex structure by the small subunit 
(r.m.s.d. = 0.336) reveals drastic domain movements and rotations around these linkers. The 
N-terminal domain containing the [4Fe4S] cluster of CoFeSP rotates by almost 90° and the 
cluster is translocated by 42 Å (Figure 38). Consequently many interactions with the RACo 
homodimer are formed and contribute to the stabilisation of the complex (Figure 37A and B). 
 
Figure 38: Domain movements of CoFeSP. Superimposition of free CoFeSP (red, PDB 2YCL) (94) and 
CoFeSP in complex with RACo (blue) by the small subunit CfsB. Distances between the cofactors are indicated 
by a green (free CoFeSP) and orange (complex) arrow. 
As shown in Figure 37A and B residues of the middle domain of one RACo monomer and 
residues of the ASKHA domain of the other RACo monomer interact with the N-terminal 
domain of the large subunit of CoFeSP. Usually, the N-terminally bound [4Fe4S] cluster 
binding domain of CoFeSP is mobile (89, 94) and plays not only a crucial role in the 
stabilisation of the RACo:CoFeSP complex but also in the complex of CoFeSP and 
methyltransferase of M. thermoacetica which has been solved recently (98). Functionally, the 
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two complexes are unrelated but both crystal structures demonstrate that CoFeSP employs its 
flexible domains to interact with different protein partners (Figure 39A). “Dynamic domain 
juggling” in the methyl transfer complex  is quantified by a displacement of 6.5 – 14.8 Å (98). 
In the activation complex this “domain juggling” induces movements of 20 – 42 Å compared 
to uncomplexed CoFeSP (Figure 39). 
 
Figure 39: Domain flexibility of CoFeSP. Comparison of the relative positions of the flexible C-and N-
terminal domain of CoFeSP in free CoFeSP of C. hydrogenoformans (red, PDB 2YCL) (94), CoFeSP bound to 
MeTr of M. thermoacetica (green, PDB 4DJD) (98) and CoFeSP bound to RACo (blue). All structures were 
aligned by superimposition to the small subunit, CfsB (white surface presentation). 
The C-terminal domain of CfsA, carrying the cobalamin cofactor, moves by 20 Å and rotates 
by 45° around the linker connecting it to the (β/α)8 barrel domain. The cobalamin moves from 
its interaction interface with the small subunit towards the surface of RACo (Figure 36, 
Figure 39).  
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5.3. Coordination Environment of the Cobalamin 
Like in free CoFeSP the cobalamin cofactor is bound “base-off” in the complex but nestled by 
several residues of the ASKHA domain of RACo (D246, T380, N381, S398, A399, N509 and 
R512). The hydroxyl group of a serine residue of RACo replaces the axial water ligand on the 
β-side of the corrin macrocycle with a Co–O distance of 2.5 Å while the interaction of the Co-
ion and T374 is retained in the complex structure (Figure 40A). The corrin cycle is placed in a 
surface cavity of RACo with its ring fitting perfectly in this cobalamin-binding pocket (Figure 
40B).  
 
Figure 40: Environment of the cobalamin cofactor. (A) Interactions between the corrin ring (cyan stick 
model) and RACo (pink). The residues interacting with cobalamin are shown as sticks and interactions are 
denoted by black dashes. (B) Cobalamin (yellow spheres) confined in the corrin-binding pocket of RACo (pink 
surface). 
The complex structure revealed a direct interaction of the Co-ion with a residue of RACo. The 
serine residue 398 was mutated to either alanine or cysteine (Materials and Methods 3.2.3) to 
investigate the influence of this residue on the dissociation constant of the RACo:CoFeSP 
complex by ITC (Materials and Methods 5.5). The Serine398 mutants of RACo have a lower 
affinity towards Co(II)-CoFeSP and the dissociation constants determined by ITC are 3.8. ± 
0.5 µM for S398A and 16.9 ± 0.6 µM for S398C, respectively (Figure 41). These constants 
underline the importance of this residue in the selective redox-state-dependent partner 
recognition. 
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Figure 41: ITC data of the titration of CoFeSP with RACo-S398A (A) and RACo-S398C (B). Shown are 
the binding isotherms with exothermic heat changes and the fits of the integrated enthalpy changes to a one-site 
binding model. The dissociation constants KD are 3.8. ± 0.5 µM for RACo-S398A and 16.9 ± 0.6 nM for RACo-
S398C, respectively. 
The complex structure demonstrates how the environment of the cobalamin cofactor is 
influenced by the interactions with RACo and explains the results obtained earlier by 
resonance Raman and EPR spectroscopy as well as the manipulated redox potential of the 
cobalamin (Results and Discussion 4.3).  
In free CoFeSP the corrin macrocycle is positioned between CfsB and the C-terminal domain 
of CfsA (89, 94) and bound “base-off/His-off”, i. e. the lower methoxybenzimidazolyl moiety 
does not coordinate the cobalt neither does a protein bound histidine residue (Figure 10B). On 
the upper face (β-side) of the corrin cycle, a water molecule coordinates the cobalt ion with a 
Co–O distance of 2.5 Å. On the lower face (α-side), Thr374 of the cap-helix is at 3.6 Å 
distance from the cobalt. The loose interactions are displayed in the EPR spectrum of as-
isolated CoFeSP with a broad and less resolved signal in the low field side (Figure 32A). The 
active Co(I)-state is favoured by the base-off conformation and stabilised by around 100 mV 
compared to base-on or His-on cobalamins (68). The redox potential of –450 mV, determined 
by redox titration (Figure 33), is in good agreement with the coordination environment found 
in free CoFeSP. 
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The decrease of the midpoint potential of the Co(II)/Co(I) couple in the RACo:CoFeSP 
complex from –450 to a potential below –600 mV (Figure 34) certainly derives from the 
interactions with the protein matrix of RACo, especially with Ser398. Co(II)-cobalamins 
prefer a penta-coordination and the structure demonstrates how the Co(II)-state is stabilised 
by a strong axial ligand (Figure 40A) (136). The redox-dependent complex formation can 
now be explained by the coordination chemistry of the cobalamin (Figure 42) (136). A direct 
interaction of Ser398 and the cobalt ion is only reasonable in the inactive Co(II) state. While 
the active Co(I) state prefers tetracoordination without axial ligands, the active CH3-Co(III) 
state binds a methyl group, which cannot easily be replaced by the hydroxyl group of the 
serine residue.  
 
Figure 42: Coordination chemistry of the cobalamin. The favoured coordination of the different cobalamin 
redox states is presented. States, active in the reductive acetyl-CoA pathway, are labelled in green, whereas the 
inactive state is marked in orange. The tendency of the different states to form a complex with RACo is 
indicated.  
Strengthening of the interaction with an axial ligand was indicated by the EPR spectrum of a 
complex sample and was manifested by sharper signals compared to the cobalamin signals of 
uncomplexed CoFeSP where a loose interaction to an axial water ligand is displayed (Figure 
32). An impact on the redox potential upon complex formation had already been implied by 
resonance Raman spectroscopy. Changes observed in the RR spectra are assigned to the 
redox-state sensitive C=C stretching modes. Frequency downshifts are usually explained by 
an increase of electron density on the metal ion and concurrent weakening of the C=C bonds 
as observed in the spectrum of reduced CoFeSP (Figure 29B). Upshifts are expected for 
oxidation and were described for the Co(II)/Co(III) couple at 1543 and 1604 cm-1 (127). The 
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upshifts from 1543 to 1545 cm-1 and from 1604 to 1607 cm-1 in the complex spectrum (Figure 
29D) should not derive from incidental oxidation to the Co(III)-state but could display the 
stabilisation of the Co(II) state. 
The Co(II) state is stabilised by burying the corrin moiety inside a surface pocket of RACo 
(Figure 40). To position the corrin cycle into the pocket, CoFeSP performs a displacement of 
two complete domains (Figure 38 and Figure 39). Adaption of different conformations during 
the catalytic cycle was proposed and discussed earlier (89). The manifoldness of CoFeSP in 
adapting different conformations depending on the interaction partner has to be enlarged and 
replenished by an activation conformation found in the RACo:CoFeSP complex (Figure 43).  
 
Figure 43: Overview of the different CoFeSP conformations. MT-Conform 1 (a) and 2 (d) describe the 
conformation during methyl group transfer when CoFeSP interacts with ACS or MeTr, respectively. The Cap-
Conform (c) is the inactive Co(II)-state as observed in as isolated CoFeSP (89, 94). Red-Conform (b) represents 
the conformation during the suggested activation of Co(II)-CoFeSP under participation of its FeS cluster (99, 
100). Conformations a-d are taken from Svetlitchnaia et al. (89). A new conformation, the activation-Conform 
(e) as part of the activation complex with RACo, has been included in the reaction scheme. 
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5.4. Conformational Changes on RACo 
Complex association commonly induces conformational changes on at least one protein 
involved. In all ATP dependent activation systems described so far, conformational changes 
have been mainly observed on the ATPases. Additionally to the domain rearrangements 
described for CoFeSP, conformational changes on RACo are evident. 
RACo is assigned to the ASKHA protein family since the large C-terminal domain resembles 
the typical core fold with a βββαβαβα topology (47, 48). Many members of the ASKHA 
family exist in two conformations. Commonly, binding of the (sugar) substrate, the 
nucleotide, a metal ion or a combination of the different ligands trigger protein motion (48, 
137–139). The binding of the nucleotide to the open conformation of actin and hsc70 for 
example solely induces conformational changes and provokes the closure of the binding site 
(140, 141).  
The crystal structure of RACo represents with a phosphate bound in the narrow cleft between 
the two subdomains of the ASKHA domain a closed conformation (Figure 12 and Figure 44, 
blue). The comparison of the structures of complexed and free RACo upon superimposition 
of the middle domains (r.m.s.d. = 0.342) demonstrates that the narrow cleft has opened upon 
complex formation (Figure 44, purple). Residues of this domain are displaced by up to 16 Å. 
Two generic helices are rotated by 19 and 25 °, respectively (Figure 44A). As a consequence 
of the conformational changes observed on RACo, H-bonds and salt bridges are formed 
between these residues and CfsB (Figure 37C) and the corrin macro cycle (Figure 40A). 
Surface presentations of the two conformers visualise the opening of the nucleotide-binding 
site in the cleft between the subdomains I and II of the ASKHA domain. Displacement of 
subdomain II results in the formation of the corrin-binding pocket in which the corrin 
macrocycle perfectly suits (Figure 44B). 
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Figure 44: Conformational changes on RACo upon complex formation. (A) Free RACo (blue, PDB 3ZYY) 
(102) superimposed to CoFeSP-bound RACo (purple) by the middle domain (residues 125-205). Only 
subdomain II is coloured; parts of the structure not affected by the interaction with CoFeSP are illustrated in 
grey. The Mg2+ and PO43- bound in free RACo are shown as spheres. Orange arrows highlight the displacement 
of two generic helices. (B) Closed and open conformation of the ASKHA domain of RACo. Surface presentation 
of the activator of CoFeSP in the RACo:CoFeSP complex (above) and of free activator (below) in two 
orientations. The open cleft representing the nucleotide-binding site and the open corrin-binding pocket (with 
cobalamin depicted as yellow sticks) are indicated. The closed cleft and pocket are marked with a red X. 
The activator of 2-hydroxyisocaproyl-CoA dehydratase from Clostridium difficile also belong 
to the ASKHA fold protein family and exist in a closed and an open conformation (Figure 
45A) (50). Superimposition of the two states of the activator of 2-hydroxyisocaproyl-CoA 
dehydratase by domain II revealed a relocation of domain I. Helix 1 is displaced by 19 Å 
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increasing the angle between domain I and II by 40° (Figure 45B) (50). The dislocation and 
rotation within the ASKHA domain of RACo and the activator of 2-hydroxyisocaproyl-CoA 
dehydratase are similar. Nevertheless, both conformations of the latter were observed in the 
absence of the dehydratase.  
 
Figure 45: Closed and open conformation of the activator of (R)-2-hydroxyisocaproyl-CoA dehydratase. 
(A) Surface presentation of the activator of (R)-2-hydroxylisocaproyl-CoA dehydratase with ADP bound 
representing the closed conformation (green, PDB 4EHT) and the open, e.g. nucleotide free state (red, PDB 
4EIA) (50). ADP bound to the closed conformation is shown as stick model, the [4Fe4S] cluster is illustrated as 
spheres (sulfur atoms in yellow, iron atoms in orange). (B) Superimposition of the monomers of the closed and 
open conformation based on Cα atoms of domain II. The monomers are shown as ribbon and are coloured as in 
(A). ADP (bound to the closed conformation) is illustrated as sticks and the FeS cluster as spheres. The second 
monomer of the closed state is hinted in light blue. The figure was prepared and modified from Knauer et al. 
(50). 
The dislocation of the ASKHA domain allows for the creation of the corrin-binding pocket, 
which is too narrow for the corrin cycle to fit in in the closed conformation (Figure 46).  
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Figure 46: Closed and open corrin-binding pocket. The corrin ring of the cobalamin cofactor (yellow stick 
model) and the binding pocket of RACo in the open conformation (pink surface presentation) show a nearly 
perfect fit as illustrated in Figure 40B. In the closed conformation (PDB 3ZYY (102), grey surface) the pocket is 
not wide enough to accommodate the corrin ring and it is partially covered. The serine 398 coordinating directly 
the cobalt ion in the complex is marked with an asterisk (white in RACo, black in the complex).  
The conformational changes on RACo result in the loss of a β-strand within the ASKHA 
domain (residues 547-549) interacting with a β-strand of the linker domain (residues 110-112) 
(Figure 47A). The lacking “fixation” (Figure 47B) could be an explanation why this domain 
is highly disordered in the complex and provides an even higher mobility resulting in a bigger 
operating range of the electron donor domain. 
 
Figure 47: Loss of the interaction between two β-strands may result in higher flexibility of the linker 
domain. (A) The interaction of a β-strand of the linker domain (green cartoon) and a β-strand (red) of the 
ASKHA domain observed in the RACo structure (PDB 3ZYY) (102). (B) In the RACo:CoFeSP complex, this 
interaction is lost due to the opening of the ASKHA domain. Shown is the linker domain of the single RACo 
structure. The residues forming the β-strand are coloured as in (A).  
 87 
IV.   
IV. CONCLUSION 
Scheme of the Mechanism of the Reductive Activation of CoFeSP by RACo 
Based on the results obtained in this study (Results and Discussion 3, 4 and 5), a mechanism 
for the reductive activation of CoFeSP by RACo can be drawn (Figure 48). 
 
Figure 48: Proposed mechanism of the ATP-dependent reductive activation of CoFeSP by its activator 
RACo. Available protein structures (PDB 2YCL (94) and 3ZYY (102)) are shown as surfaces, whereas contour 
plots illustrate theoretical intermediary states not captured in crystal structures. The coordination of the 
cobalamin cofactor in every state is sketched; the open corrin-binding pocket is illustrated with green, an orange 
triangle indicates the open ATP-binding site. Dashed lines demonstrate movements. The activation mechanism is 
described in detail in the text. For clarity, only the complex monomer is shown.  
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I.) A transient complex is formed between RACo in its closed conformation and the 
inactive resting state of CoFeSP. 
II.) Conformational changes on RACo, i.e. switching from the closed to the open state, 
result in the expansion of the nucleotide-binding cleft. Simultaneously, the corrin-
binding pocket is created. 
III.) Upon complete formation of the binding pocket, the cobalamin-binding domain of 
CoFeSP adapts a new conformation (activation conform, Figure 43) and places the 
corrin ring into the corrin-binding pocket where it is engaged in a tight hydrogen 
bonding network including direct interaction between the cobalt ion and Ser398 of 
RACo. In the activation complex, Co(II) is highly stabilised and without energy input 
a reduction to the active Co(I) is not achieved. 
IV.) Binding of ATP induces the closure of RACo, straightens the corrin pocket and results 
in a weakening of the interactions between the ASKHA domain of RACo and CfsB. 
As the corrin ring has been tightly fit into the pocket, it transiently adopts a square-
planar geometry like it is favoured in the Co(I)-cobalamin. Water cannot replace the 
hydroxyl group of Ser398 as axial ligand since simply no space is provided. The 
[2Fe2S] cluster transfers its electron just in the right moment when ATP hydrolysis 
provides the energy needed to overcome the potential barrier and to break the complex 
completely.  
V.) Active Co(I)-CoFeSP can now return to the catalytic cycle, and RACo in its closed 
conformation is prepared to reactivate another inactive Co(II)-CoFeSP. 
It cannot be clearly concluded which event (I or II) during complex formation occurs first. As 
the corrin-binding pocket cannot be formed in RACo´s closed conformation and the opening 
is induced by interactions between CfsB and RACo (Figure 37C), it is more likely that 
conformational changes upon complex formation on the activator happens first, followed by 
bending over the cobalamin to its new “accommodation”.  
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The tight interactions between the corrin macrocycle and residues of the ASKHA domain of 
RACo, especially the direct interaction with Ser398 (Figure 40A), modulate the midpoint 
potential of the cobalamin cofactor and stabilise the inactive Co(II) state (Results and 
Discussion 4.3.3, Figure 40) supported also by a small dissociation constant (Results and 
Discussion 4.2.2, Figure 28). The dependency of the electron transfer reaction on ATP was 
shown (Results and Discussion 4.1) but it could not be proved whether nucleotide-binding or 
hydrolysis triggers the reduction. Definitely, energy input is mandatory to provoke the 
dissociation of the stable RACo:CoFeSP complex (ΔGbinding of – 44 kJ/mol); the hydrolysis of 
one molecule of ATP (approximately ΔGATP of – 48 kJ/mol) (142) or the binding in 
combination with conformational changes, have to promote the reactivation of CoFeSP. 
Different models of electron transfer in nitrogenase like the “deficit spending” model suggest 
that ET is gated by conformational changes on the Fe-protein and that the hydrolysis of ATP 
induces complex dissociation (35, 132). Recently, Duval et al. (43) were able to complete the 
thermodynamic cycle of the Fe-protein during nitrogenase reduction and showed that 
interprotein ET is not directly coupled to the hydrolysis of ATP. Phosphate release and 
complex dissociation mark the last steps (43). Hence, ET in nitrogenase is driven by the free 
energy of ATP binding and protein-protein association. (43, 132). Compared to the Fe-protein 
both, the electron transfer (Results and Discussion 4.1.1) and the ATP hydrolysis rates 
(Results and Discussion 3.2) of RACo are low. The reductive activation of CoFeSP by RACo 
represents a “rescue” mechanism. Hence, it is just required occasionally and fast turnovers are 
less mandatory than during the reduction of one molecule of nitrogen by nitrogenase; the 
reaction depends on at least 8 successive cycles of complex association / dissociation, each 
transferring one electron and consuming two molecules of ATP (12, 18, 23, 27). Despite this 
variation, the elctron transfer between RACo and CoFeSP may also be controlled by the free 
energy of nucleotide binding and / or complex association, in compliance with nitrogenase.  
Interactions of the two proteins do not alter the donor cluster as it is proposed for the activator 
of 2-hydroxy-isocaproyl-CoA-dehydratase (135) or the Fe-protein of nitrogenase (131, 132). 
The midpoint potential of the corrinoid protein of O-demethylase increases to a moderate 
midpoint potential, i.e. comparable to the one of the donor cluster, in the presence of the 
activating enzyme (16, 17). In contrast to nitrogenase or dehydratase, the donor cluster on 
RACo as well as the accepting cofactor on CoFeSP is bound to flexible domains. The FeMo-
cluster of nitrogenase and the acceptor [4Fe4S] cluster in dehydratase are buried in the protein 
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and cannot be accessed directly (24, 49); direct modulation by the activator or reductase is 
precluded. Hence, the stabilisation of the Co(II) state in the RACo:CoFeSP complex is 
enabled by the modular architecture of both proteins. The modular protein methionine 
synthase in the reactivation conformation (juxtaposition of the cobalamin- and AdoMet-
binding domains) is capable of altering the reduction potential of the Co(II)/Co(I) couple by 
elongation of the bond between the cobalt ion and its upper axial water ligand. Thus, 
reduction by flavodoxin is facilitated by the adaption of a 4-coordinate cobalamin (143). In 
the RACo:CoFeSP complex, ATP-binding may provoke the elongation of the bond between 
Ser398 and the Co-ion, destabilise the Co(II) state and favour the transition to the preferred 
Co(I)-geometry. This temporarily adapted square-planar Co(I)-like coordination may facilitate 
the reduction of cobalamin, like reported for MetH (143). Thereby the sensitive Co(I) state is 
protected by the tight fit of the corrin-binding pocket since no water molecule can compensate 
the loss of the axial protein ligand.  
In the ATP-dependent electron transfer systems of nitrogenase, radical-dependent β,α-
dehydratases and the related benzoyl- CoA reductases, the functional unit is the activator / 
reductase dimer. Contrary to these systems, the RACo monomer, each binding one [2Fe2S] 
cluster, acts as functional unit in the reductive activation of CoFeSP, which is also reflected in 
the stoichiometry of the ternary activation complex between one RACo dimer and two 
CoFeSP heterodimers (Results and Discussion 4.2 Figure 26 and 5.1, Figure 36). 
In conclusion, oxidation-state-dependent partner recognition (Results and Discussion 4.2.1) 
combined with a manipulation of the electron accepting site (Results and Discussion 4.3 and 
5.3) and balance of binding energies (Results and Discussion 4.2.2) represents a feasible way 
to gate the ATP-coupled electron transfer in the reductive activation of CoFeSP by its 
activator RACo.  
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V. OUTLOOK 
The characterisation of the reductive activator of CoFeSP, RACo, operating in the reductive 
acetyl-CoA pathway of Carboxydothermus hydrogenoformans, has extended the general 
knowledge about the functionality of RACE proteins. The structural and spectroscopic 
investigation of the activator:CoFeSP complex within this study have offered insights into the 
mechanism of the reductive activation of corrinoid enzymes.  
Recently, Duval et al. were able to complete the thermodynamic cycle of the Fe-protein by 
determination of the rate constants of the four sequential steps during reduction of nitrogenase 
(43). A comparable kinetic study of the single events during the reductive activation of 
CoFeSP by RACo in combination with further studies on the active site mutants of RACo 
(Results and Discussion 3.2 and 4.1.2) could be helpful to solve the enigma of the role of ATP 
and confirm or refute the suggested ATP-dependent reactivation mechanism (Conclusion, 
Figure 48).  
The increase of the cobalamin potential by the interaction with RACo (Results and Discussion 
4.3.3) is in contrast to the nitrogenase / dehydratase system where conformational changes on 
the Fe-protein and the activator of dehydratase in the presence of a nucleotide cause changes 
on the redox potential of the reducing cluster (131–135). The midpoint potential of the 
[2Fe2S] cluster of RACo was determined in the absence of a nucleotide (Results and 
Discussion 3.3). Redox titration could be repeated with ATP or ATP-analogues to exclude 
modulations on the donor site. 
In the structure of the RACo:CoFeSP complex the N-terminal domain of RACo and parts of 
the linker are unresolved (Results and Discussion, Figure 36), probably due to the high 
flexibility of the long linker domain or as a result of proteolysis during the long crystallisation 
process. Even though the domain does not contribute to the stability of the complex (Results 
and Discussion 4.2, 4.3.1 and 5.1), its position could shed light on how the electron is 
transferred to the cobalamin. The distance between the metals involved in the electron transfer 
from RACo to CoFeSP could be detected in pulsed electron–electron double resonance 
(PELDOR or DEER) experiments (144). Fluorescence resonance energy transfer (FRET) 
(145) enables the measurement of changes in molecular distances and could be performed to 
get further insights into the kinetics of domain movements (Results and Discussion 5.2 and 
5.4) during the reductive activation of CoFeSP by RACo.  
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VII. APPENDIX 
A. Appendix Tables 
1. Cloning and Mutagenesis of RACo 
Table 10: Primers used in cloning and mutagenesis of RACo. 
Primer Sequence 5´ 3 
Cloning of RACo (pPKCoDuet1 & pET28a) 
Orf7_fwd CAG CCA TAT GGC AGA ATA TAA AGT TTT G 
Orf7_rev GCA CTC GAG TTA TTC TAC TGA AGG AAA TAG ATG 
Deletion of N-terminal Domain (PIPE cloning into pET28aTEV) 
RACo100+_fwd CTT GTA TTT CCA GGG CCA TTC TGG AGT TAT GAA TGA ATT AGA TTT 
AGC GG 
RACo100+_rev CGA CGG AGC TCG AAT TCG GAT CCG GAT CCT TAT TCT ACT GAA GGA 
AAT AGA TGC AAA TCG G 
Active Site Mutants (QuickChange Method, pPKCoDuet1TEV) 
R_D212A_fwd CTT TGG TTT AGC AAT TGC TAT TGG CAC CAC TAC TGT 
R_D212A_rev ACA GTA GTG GTG CCA ATA GCA ATT GCT AAA CCA AAG 
R_T215A_fwd TAG CAA TTG ATA TTG GCG CCA CTA CTG TTG TGG TGC AAT TG 
R_T215A_rev CAA TTG CAC CAC AAC AGT AGT GGC GCC AAT ATC AAT TGC TA 
R_D377A_fwd GAA ATA ACC CTA TTT ATC GCT ATC GGG ACA AAC GGA GAA ATG 
R_D377A_rev CAT TTC TCC GTT TGT CCC GAT AGC GAT AAA TAG GGT TAT TTC 
R_T380A_fwd ATT TAT CGA TAT CGG GGC AAA CGG AGA AAT GGT TCT TGG CAA 
R_T380A_rev TTG CCA AGA ACC ATT TCT CCG TTT GCC CCG ATA TCG ATA AAT 
R_E404A_fwd CAG CGG GTC CAG CGT TTG CAG GAA GCG GAA TTA AGC 
R_E404A_rev GTG CTT AAT TCC GCT TCC TGC AAA CGC TGG ACC CGC 
Residues involved in cobalamin coordination (PIPE cloning into pET28aTEV) 
Orf7_fwd CAG CCA TAT GGC AGA ATA TAA AGT TTT G 
Orf7_rev GCA CTC GAG TTA TTC TAC TGA AGG AAA TAG ATG 
R_S398A_fwd TGG CTT GTA ACT TGC GCC TGC GCA GCG GGT CCA GCG TTT GAA GGA 
AGC GG 
R_S398A_rev 
  
CCG CTT CCT TCA AAC GCT GGA CCC GCT GCG CAG GCG CAA GTT ACA 
AGC CA 
R_S398C_fwd TGG CTT GTA ACT TGC GCC TGC TGT GCG GGT CCA GCG TTT GAA GGA 
AGC GG 
R_S398C_rev CCG CTT CCT TCA AAC GCT GGA CCC GCA CAG CAG GCG CAA GTT ACA 
AGC CA 
 104 
  APPENDIX 
1.1 Deletion of the N-terminal Domain (Residues 1-100) 
Table 11: PCR reaction mix for the deletion of the N-terminal domain of RACo. 
 
 
Table 12: Temperature programme for the deletion of the N-terminal domain of RACo. 
Step Temperature Duration 
Initial Denaturation 98 °C 2 min 
Denaturation 98 °C 10 s 
10 s                x35  
22 s 
Annealing 63 °C 
Extension 72 °C 
1.2 Active Site Mutants (QuickChange Method) 
Table 13: Mutagenesis reaction mix used for the preparation of active site mutants of RACo. 
 
 
 
 
 
 
 
Standard PCR reaction mix Final concentration 
Template Variable, 2-10 ng 
Fwd primer (5 µM) 0.5 µM 
Rev primer (5 µM) 0.5 µM 
dNTPs (10 mM) 200 µM  
5-fold buffer for DNA Polymerase  1 fold 
Phusion DNA Polymerase 1.0 units/50 µL PCR 
Nuclease free water Added to 50 µL 
Standard Mutagenesis reaction mix Final concentration 
Template pPKCoDuet1-TEV, variable, 5 – 50 ng 
Fwd primer (5 µM) 0.5 µM 
Rev primer (5 µM) 0.5 µM 
dNTPs (10 mM) 200 µM  
10-fold buffer for DNA Polymerase  1 fold 
PfuTurbo DNA Polymerase 2.5 units/µL  
Nuclease free water Added to final volume of 50 µL 
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Table 14: Temperature program for Quick Change Mutagenesis. 
1.3 Mutation of Ser398 by combining PIPE cloning and QuickChange Method 
Table 15: PCR reaction mix for the preparation of Ser398 mutants. 
 
 
Table 16: Temperature programme used in the preparation of Ser398 mutants. 
Step Temperature Duration 
Initial Denaturation 98 °C 30 s 
Denaturation 98 °C 10 s 
30 s                x 25 
1 min 
Annealing  55 °C 
Extension 72 °C 
Final Extension 72 °C 10 min 
 
 
Step Temperature Duration 
Initial Denaturation 95 °C 0.5 min 
Denaturation 95 °C 0.5 min 
1 min                    x 12 
6 min 
Annealing 55 °C 
Extension 68 °C 
Final Extension 68 °C 10 min 
Standard PCR reaction mix Final concentration 
Template Orf7, variable 1 and 5 ng 
Fwd primer (5 µM) 0.5 µM 
Rev primer (5 µM) 0.5 µM 
dNTPs (10 mM) 200 µM  
5-fold buffer for DNA Polymerase  1 fold 
Phusion DNA Polymerase 1.0 units/50 µL PCR 
Nuclease free water Added to 50 µL 
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2. Cloning and Mutagenesis of CoFeSP 
Table 17: Primers used in the cloning and mutagenesis of CoFeSP. 
Primer Sequence 5´ 3 
 
Deletion of C-terminal Domain of CfsA (PCR:Religate:Transform) 
acsCD_NM_fwd GAA CAG AAA GTA ATC GTA TTG TAC ACG GCC 
acsCD_MCNM_rev TTA TTT CTG CGG GTC GGT GTA AAT GTT AAG T 
 
Deletion of C-terminal Domain of CfsA (PCR:Religate:Transform) 
acsCD_MC_fwd ATG CCA CCG GTA GCT TTA ATT AAA GTG GGT AAA G 
pPKCD_rev  
  
Change in 4Fe4S-coordination (QuickChange Method) 
acsCD_C25P_fwd GGT CAA CCA ACT CCT CTT GCT TTT GCC ATG CAA ATT GCC G 
acsCD_C25P_rev CGG CAA TTT GCA TGG CAA AAG CAA GAG GAG TTG GTT GAC C 
2.1 Deletion of entire Domains of CfsA 
Table 18: PCR reaction mix for the deletion of domains of CfsA. 
 
 
Table 19: Temperature program of the deletion of CfsA domains. 
Step Temperature Duration 
Initial Denaturation 98 °C 2 min 
Annealing 68 °C 15 s    
4 min                         x 25           Extension 72 °C 
Final Extension 72 °C 10 min 
 
 
 
Standard PCR reaction mix Final concentration 
Template pPKCD, 1 and 10 ng 
Fwd primer (5 µM) 0.5 µM 
Rev primer (5 µM) 0.5 µM 
dNTPs (10 mM) 200 µM  
5-fold buffer for DNA Polymerase  1 fold 
Phusion DNA Polymerase 1.0 units/50 µL PCR 
Nuclease free water Added to 50 µL 
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2.2 Site directed Mutagenesis of cysteines coordinating the [4Fe4S] cluster 
Table 20: Mutagenesis reaction mix for [4Fe4S] cluster mutants. 
 
 
Table 21: Temperature programme for mutagenesis of CoFeSP. 
 
 
 
 
Standard Mutagenesis reaction mix Final concentration 
Template pPKCD, variable, 5 – 50 ng 
Fwd primer (5 µM) 0.5 µM 
Rev primer (5 µM) 0.5 µM 
dNTPs (10 mM) 200 µM  
10-fold buffer for DNA Polymerase  1 fold 
PfuTurbo DNA Polymerase 2.5 units/µL  
Nuclease free water Added to final volume of 50 µL 
Step Temperature Duration 
Initial Denaturation 95 °C 1 min 
Denaturation 95 °C 0.5 min 
1 min                    x 16 
9 min 
Annealing 55 °C 
Extension 68 °C 
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3. Statistics of Data collection and refinement of the RACo:CoFeSP complex 
Table 22: Statistics of data collection and refinement of the complex structure. Highest resolution shell is 
shown in parenthesis 
 RACo:CoFeSP complex 
Data collection  
Space group P1 
Cell dimensions    
    a, b, c (Å) 67.13, 128.18, 163.37 
    α, β, γ  (°)  77.61, 82.25, 88.76 
Resolution (Å) 30 – 2.53 (2.60  – 2.53)* 
Rsym  0.092 (0.535) 
I / sI 9.99 (2.60) 
Completeness (%) 96.05 (88.26) 
Redundancy 2.74 (2.70) 
  
Refinement  
Resolution (Å) 30  – 2.53 
No. reflections 168 978 
Rwork / Rfree 0.2042 / 0.2559  
No. atoms 40 235 
    Protein 38 562 
    Ligand/ion 396 
    Water 1277 
B-factors  
    Protein 29.60 
    Ligand/ion 22.36 (B12), 38.68 (4Fe4S) 
    Water 28.90 
R.m.s. deviations  
    Bond lengths (Å) 0.011 
    Bond angles (°) 1.29 
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B. Appendix Figures 
1. Modified purification of RACo 
 
Figure 49: Chromatograms and SDS-PAGEs of the different purification steps of the modified RACo 
purification (Materials and Methods 2.1.2). (A) Elution profile of IMAC using Ni-SHP material and SDS-
PAGE analysis of the pooled fractions (red box). (B) Chromatogram of the second purification step (IEC) and 
SDS-PAGE analysis of the combined fractions (red box). (C) After TEV-cleavage the fraction was loaded onto a 
S200 column for SEC. SDS-PAGE analysis of the final protein fraction is shown.  
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2. Standard curve used for the MGAM assay 
 
 
Figure 50: Standard curve for the calculation of the amount of released inorganic phosphate in the 
malachite green assay (Materials and Methods 6.1.1). 
3. Standard curve used in analytical size exclusion chromatography 
 
 
Figure 51: Standard curves used in analytical gel filtration (Materials and Methods 5.4). (A) SuperdexTM 
200 prep-grade gel filtration column (120 mL, GE Healthcare). The logarithms of the molecular weights of 
several proteins were plotted against the corresponding elution volumes. As marker proteins 1 mg of Lactate 
Dehydrogenase (140 kDa, 69.2 mL), Conalbumin (75 kDa, 78.6 mL), Ovalbumin (43 kDa, 85.7 mL) and 
Ribonuclease (13.7 kDa, 100.7 mL) were loaded to the column and run in 50 mM Tris/HCl, pH 8.0, 150 mM 
NaCl, 2 mM DTT. (B) S200 5/150 (3 mL, GE Healthcare). As marker proteins 1 mg of Lactate Dehydrogenase 
(140 kDa, 1.81 mL), Conalbumin (75 kDa, 1.87 mL), Ovalbumin (43 kDa, 2.11 mL) and Ribonuclease 
(13.7 kDa, 2.35 mL) were loaded to the column and run in 50 mM Tris/HCl, pH 8.0, 150 mM NaCl, 2 mM DTT. 
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4. Dependency of the electron transfer rate on the ATP-concentration 
 
Figure 52: The rate of electron transfer depends on the ATP concentration. Observed rate constants for ET 
were determined by single-exponential fits were 0.089 min−1 with 0.1 mM ATP, 0.150 min−1 with 0.5 mM ATP, 
and 0.288 min−1 with 2 mM ATP. 
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VIII.  LIST OF ABBREVIATIONS 
Å       Ångström 
ACS       Acetyl-CoA-Synthase 
ADP       Adenosin-5´-diphosphate 
AE       Activating Enzyme 
APS       Ammoniumperoxodisulphate 
ASKHA Acetate and Sugar Kinases / Heat Shock 
protein 70/Actin 
ATP       Adenosin-5´-triphosphate 
BSA       Bovine serum albumin 
Cb       Carbenicilin 
CCP4       Collaborative Computational Project 
Cfs       CoFeSP subunit 
CODH       Carbonmonoxide Dehydrogenase 
CoFeSP      Corrinoid/Iron-Sulfur Protein 
CP       Corrinoid Protein 
DEAE       Diethylaminoethyl 
DT       Dithionite 
DTT       Dithiothreitol 
EPR       Electron Paramagnetic Resonance 
ET       Electron Transfer 
HEPES 4-(2-hydroxyethyl)-1-piperazine-
ethanesulfonic acid 
HIC       Hydrophobic Interaction Calorimetry 
IEC       Ion Exchange Chromatography 
IMAC Immobilised Metal Affinity Chromatography 
ITC       Isothermal Titration Calorimetry 
kcat       Catalytic rate constant 
Kd       Dissociation constant 
Km       Michaelis constant 
Km       Kanamycin 
LB       Luria Bertani 
MGAM      Malachite Green-Ammonium Molybdate 
MetH       Methionine Synthase 
MeTr / MT      Methyltransferase 
mTB       modified Terrific Broth 
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VIII. 
NADH Nicotinamide Adenine Dinucleotide, reduced 
form 
NTP       Nucleoside-5´-triphosphate 
OD600       Optical density at 600 nm 
Orf       Open Reading Frame 
PAGE       Polyacrylamide gel electrophoresis 
PCR       Polymerase chain reaction 
PDB       Protein data bank 
PEG       Polyethylene glycol 
Pi       Inorganic phosphate 
PIPE        Polymerase Incomplete Primer Extension 
RACE       Reductive Activase of Corrinoid Enzymes 
RACo       Reductive Activator of CoFeSP 
r.m.s.d.       root-mean-square deviation 
rpm       rotation per minute 
RR       Resonance Raman 
SDS       Sodium dodecyl sulphate 
SEC       Size Exclusion Chromatography 
SHE       Standard hydrogen electrode 
SHP       Sepharose High Performance 
TEMED      N,N,N',N'-Tetra-methylethylenediamine 
Tris       Tris-(hydroxymethyl)-aminomethane 
U       Unit 
UV-vis       Ultra-violet visible 
v/v       volume per volume 
w/v       weight per volum 
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